The science of oligonucleotides is advancing, but advanced manufacturing techniques are needed to optimize their impact

<!DOCTYPE html> <html lang="en"> <head><meta http-equiv="X-UA-Compatible" content="IE=edge" /> <meta charset="utf-8">  <title>The science of oligonucleotides is advancing, but advanced manufacturing techniques are needed to optimize their impact</title> <meta name="generator" content="TYPO3 CMS"> <meta name="description" content="The science of oligonucleotides is advancing, but advanced manufacturing techniques are needed to optimize their impact"> <meta name="viewport" content="width=device-width, initial-scale=1.0"> <meta name="keywords" content="Oligonucleotides, advanced manufacturing, CRB, Asahi Kasei Bioprocess, Brian Crawford, Doug Chritton"> <meta property="og:site_name" content="The Medicine Maker"> <meta property="og:title" content="The Status Quo of Oligonucleotides Is Not the Future"> <meta property="og:description" content="The science of oligonucleotides is advancing, but advanced manufacturing techniques are needed to optimize their impact"> <meta property="og:image" content="https://themedicinemaker.com/fileadmin/_processed_/0/e/csm_1224-900-Sponsored-Ashei-Kasei-Teaser_0be9b27507.png"> <meta property="og:url" content="https://themedicinemaker.com/manufacture/the-status-quo-of-oligonucleotides-is-not-the-future"> <meta name="twitter:card" content="summary_large_image"> <meta name="twitter:site" content="@medicine_maker"> <meta property="fb:app_id" content="106767766439215"> <link rel="stylesheet" href="/_assets/b3c028668ed2e6c778f28eb95a188217/Css/texeremagazine-tmm.css?1739366525" media="all"> <link href="/_assets/b3c028668ed2e6c778f28eb95a188217/Css/fonts.css?1739366525" rel="stylesheet" > <script> /*<![CDATA[*/ /*TS_inlineJS*/ var vueMenu = {};vueMenu.rootLine =[5295,11405,11766,12047];vueMenu.url = "/?type=79541325"; /*]]>*/ </script> <link rel="preload" as="font" crossorigin="crossorigin" type="font/woff" href="/_assets/b3c028668ed2e6c778f28eb95a188217/Fonts/NunitoSans/nunito-sans-regular.woff"> <link rel="preload" as="font" crossorigin="crossorigin" type="font/woff" href="/_assets/b3c028668ed2e6c778f28eb95a188217/Fonts/NunitoSans/nunito-sans-700.woff"> <link rel="preload" as="font" crossorigin="crossorigin" type="font/woff" href="/_assets/b3c028668ed2e6c778f28eb95a188217/Fonts/NunitoSans/nunito-sans-900.woff"> <link rel="preload" as="font" crossorigin="crossorigin" type="font/woff" href="/_assets/b3c028668ed2e6c778f28eb95a188217/Fonts/IconFont/texere.woff?gwu9wl"> <meta name="google-site-verification" content="3dOUsQ3Hs79KLNuVfML_tODcnN65y71HoRfEGXDwzQs" /> <link rel="apple-touch-icon" sizes="180x180" href="/_assets/0c58305e871dd9f8ce4eac97ab4d8b2c/Icons/Favicons/apple-touch-icon.png"> <link rel="icon" type="image/png" sizes="32x32" href="/_assets/0c58305e871dd9f8ce4eac97ab4d8b2c/Icons/Favicons/favicon-32x32.png"> <link rel="icon" type="image/png" sizes="16x16" href="/_assets/0c58305e871dd9f8ce4eac97ab4d8b2c/Icons/Favicons/favicon-16x16.png"> <link rel="manifest" href="/_assets/0c58305e871dd9f8ce4eac97ab4d8b2c/Icons/Favicons/site.webmanifest"> <link rel="mask-icon" href="/_assets/0c58305e871dd9f8ce4eac97ab4d8b2c/Icons/Favicons/safari-pinned-tab.svg" color="#F15D22" /> <link rel="shortcut icon" href="/_assets/0c58305e871dd9f8ce4eac97ab4d8b2c/Icons/Favicons/favicon.ico"> <meta name="application-name" content="The Medicine Maker"> <meta name="msapplication-TileImage" content="/_assets/0c58305e871dd9f8ce4eac97ab4d8b2c/Icons/Favicons/mstile-150x150.png"> <meta name="msapplication-TileColor" content="#F15D22"> <meta name="msapplication-config" content="/_assets/0c58305e871dd9f8ce4eac97ab4d8b2c/Icons/Favicons/browserconfig.xml"> <meta name="theme-color" content="#F15D22"> <script src="https://platform.illow.io/banner.js?siteId=1fa229e7-3960-4569-83a3-7709814e0af0"></script> <script src="https://cdn.p-n.io/pushly-sdk.min.js?domain_key=UiUoXBXaRzfmSEtViCVEpUc8owxtM3eFN3oz" async></script> <script> window.PushlySDK = window.PushlySDK || []; function pushly() { window.PushlySDK.push(arguments) } pushly('load', { domainKey: 'UiUoXBXaRzfmSEtViCVEpUc8owxtM3eFN3oz', sw: '/_assets/b3c028668ed2e6c778f28eb95a188217/StaticJS/pushly-sdk-worker.js', }); </script> <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-KQQMBZ8');</script> <script async defer data-website-id="0c73c0e1-f3c9-45de-921f-c4dbc4684b2a" src="https://umami.b13.live/script.js"></script> <script type="application/ld+json"> { "@context": "http://schema.org", "@type": "Article", "additionalType": "Interview", "mainEntityOfPage": "https://themedicinemaker.com/manufacture/the-status-quo-of-oligonucleotides-is-not-the-future", "headline": "The Status Quo of Oligonucleotides Is Not the Future", "articleSection": [ "Manufacture", "Advanced Medicine" ], "image": [ "https://themedicinemaker.com/fileadmin/_processed_/0/e/csm_1224-900-Sponsored-Ashei-Kasei-Teaser_b1dd01af6c.png", "https://themedicinemaker.com/fileadmin/_processed_/0/e/csm_1224-900-Sponsored-Ashei-Kasei-Teaser_151db7879d.png", "https://themedicinemaker.com/fileadmin/_processed_/0/e/csm_1224-900-Sponsored-Ashei-Kasei-Teaser_4aa58caf5e.png", "https://themedicinemaker.com/fileadmin/_processed_/0/e/csm_1224-900-Sponsored-Ashei-Kasei-Teaser_457c619968.png", "https://themedicinemaker.com/_assets/b3c028668ed2e6c778f28eb95a188217/Images/StructuredData/ArticleImageFallback/tmm-16x9.jpg", "https://themedicinemaker.com/_assets/b3c028668ed2e6c778f28eb95a188217/Images/StructuredData/ArticleImageFallback/tmm-4x3.jpg", "https://themedicinemaker.com/_assets/b3c028668ed2e6c778f28eb95a188217/Images/StructuredData/ArticleImageFallback/tmm-1x1.jpg", "https://themedicinemaker.com/_assets/b3c028668ed2e6c778f28eb95a188217/Images/StructuredData/ArticleImageFallback/tmm.jpg" ], "datePublished": "2024-11-15T00:00:00+00:00", "dateModified": "2024-11-18T16:03:15+00:00", "author": { "@type": "Organization", "name": "Asahi Kasei Bioprocess" }, "publisher": [ { "@type": "Organization", "name": "The Medicine Maker", "url": "https://themedicinemaker.com/", "logo": { "@type": "ImageObject", "url": "https://themedicinemaker.com/_assets/b3c028668ed2e6c778f28eb95a188217/Images/StructuredData/Organization/Logo/TMM-logo.png", "height": 86, "width": 600 } } ], "isPartOf": { "@type": ["CreativeWork", "Product"], "name" : "The Medicine Maker", "productID": "themedicinemaker.com:basic" }, "isAccessibleForFree": "True", "description": "The science of oligonucleotides is advancing, but advanced manufacturing techniques are needed to optimize their impact" } </script> <script type="application/ld+json"> { "@context": "http://schema.org", "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "The Medicine Maker", "item": "https://themedicinemaker.com/" }, { "@type": "ListItem", "position": 2, "name": "Manufacture", "item": "https://themedicinemaker.com/manufacture" }, { "@type": "ListItem", "position": 3, "name": "The Status Quo of Oligonucleotides Is Not the Future", "item": "https://themedicinemaker.com/manufacture/the-status-quo-of-oligonucleotides-is-not-the-future" } ] } </script> <link rel="canonical" href="https://themedicinemaker.com/manufacture/the-status-quo-of-oligonucleotides-is-not-the-future"/>  <script type="application/ld+json">[{"@context":"https:\/\/www.schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"https:\/\/themedicinemaker.com\/","name":"The Medicine Maker"}},{"@type":"ListItem","position":2,"item":{"@id":"https:\/\/themedicinemaker.com\/manufacture","name":"Manufacture"}},{"@type":"ListItem","position":3,"item":{"@id":"https:\/\/themedicinemaker.com\/manufacture\/2024","name":"2024"}},{"@type":"ListItem","position":4,"item":{"@id":"https:\/\/themedicinemaker.com\/manufacture\/2024-nov","name":"2024_Nov"}},{"@type":"ListItem","position":5,"item":{"@id":"https:\/\/themedicinemaker.com\/manufacture\/the-status-quo-of-oligonucleotides-is-not-the-future","name":"The Status Quo of Oligonucleotides Is Not the Future"}}]}]</script> <style class="tx_assetcollector">:root{--brandlogo-width:179px;--brandlogo-image-top:10px;}.b_logo--brand{display:none;}@media (min-width:768px){:root{--brandlogo-width:295px;--brandlogo-left:0;--brandlogo-top:22px;}.b_header--scroll .b_logo--brand{display:block;}} </style> </head> <body> <div id='ad-slot-27' class="b_ad"> <ga-ad code="27"></ga-ad> </div> <header id="bJS_header" class="b_header" :class="{'b_header--scroll': scrolled}"> <div class="b_header__top"> <div class="b_header__container" :class="{'b_header__container--scroll': scrolled}"> <a href="/" class="b_logo b_logo--brand b_logo--brand-tmm" title="The Medicine Maker"></a> <a href="/" class="b_brandlogo" title="The Medicine Maker"> <picture class="b_brandlogo__picture"> <source srcset="/_assets/0c58305e871dd9f8ce4eac97ab4d8b2c/Images/Logo/themedicinemaker-10-years.svg" media="(min-width: 768px)" /> <img class="b_brandlogo__image" src="/_assets/0c58305e871dd9f8ce4eac97ab4d8b2c/Images/Logo/themedicinemaker-10-years-white.svg" width="850" height="225" alt="" /> </picture> </a>  <a class="b_header__toggle" :class="{ 'b_header__toggle--menu-open' : !mobileMenuOpened, 'b_header__toggle--menu-close' : mobileMenuOpened }" v-on:click="toggleMobileMenu();" v-cloak v-if="mobileMenuEnabled && menuReady" ></a>  <div class="b_header__user-container"> <transition enter-active-class="b_transition__fade-enter-active" enter-class="b_transition__fade-enter"> <login v-cloak :mobile-menu-enabled="mobileMenuEnabled" login-page-link="/login" register-page-link="/login/sign-up" profile-page-link="" professional-information-page-link="" preferences-page-link="" my-view-page-link="" reading-list-page-link="" current-page-link="/manufacture/the-status-quo-of-oligonucleotides-is-not-the-future" brandname-label="The Medicine Maker" terms-conditions-page-link="/privacy-notice" nl-register-link="https://themedicinemaker.com/newsletter-registration?utm_source=website&utm_medium=display&utm_campaign=nl_button" nl-register-link-label="Subscribe to Newsletter" :scrolled="scrolled" :user="user" ref="login" ></login> </transition> </div> <mobile-menu :menu-data="menuData" parent-menu-link-prefix="back" v-if="mobileMenuOpened && menuReady" ref="mobileMenu" v-cloak > <template slot="header"> <div class="b_flyout-mobile__row"> <form method="get" action="/search" class="b_form b_form--gapless"> <fieldset class="b_form__fieldset b_form__fieldset--gapless"> <div class="b_form__grid"> <div class="b_form__fieldgroup b_form__fieldgroup--gapless"> <input name="q" type="text" class="b_form__textinput" value=""> <button type="submit" class="b_form__icon b_form__icon--search"></button> </div> </div> </fieldset> </form> </div> </template> </mobile-menu> <transition enter-active-class="b_transition__fade-enter-active" enter-class="b_transition__fade-enter"> <keep-alive> <main-menu :menu-data="menuData" :scrolled-header="scrolled" v-cloak v-if="!mobileMenuEnabled && menuReady && !searchOpen" ></main-menu> </keep-alive> </transition> <div class="b_search" :class="{'b_search--open': searchOpen}"> <form method="get" action="/search" class="b_search__form"> <input type="text" name="q" value="" class="b_search__input" placeholder="Search The Medicine Maker" ref="headerSearchInput"/> <button type="submit" class="b_search__submit"></button> </form> <a class="b_search__close" v-on:click="toggleSearch"></a> </div> </div> </div> <keep-alive> <main-menu-sub-pages-navigation :menu-data="mainMenuCurrentSubPage" v-if=" Object.keys(mainMenuCurrentSubPage).length > 0 && Object.keys(mainMenuCurrentSubPage.subPages).length > 0 && !mainMenuFlyoutOpen " ></main-menu-sub-pages-navigation> </keep-alive> <main-menu-flyout :menu-data="mainMenuFlyoutData" :current-page-uid="(mainMenuFlyoutUid != undefined) ? mainMenuFlyoutUid : 0" :layout="mainMenuFlyoutLayout" flyout-category1="5286" flyout-category2="5295" flyout-category3="5308" flyout-category4="" flyout-issue="4714" flyout-product-profiles="4718" flyout-appnotes="4716" flyout-powerlists="4735" flyout-awards="4778" flyout-webinars="4754" > <template slot="flyoutCategory1"> <div class="b_header__container b_header__container--bottom"> <div class="b_flyout__grid"> <div class="b_flyout__column b_flyout__column--menu"> <span class="b_flyout__title">Topics</span> <ul class="b_menu-flyout"> <li class="b_menu-flyout__item"><a href="/discovery-development/analytical-science" class="b_menu-flyout__link">Analytical Science</a></li> <li class="b_menu-flyout__item"><a href="/discovery-development/clinical-trials" class="b_menu-flyout__link">Clinical Trials</a></li> <li class="b_menu-flyout__item"><a href="/discovery-development/contract-development-services" class="b_menu-flyout__link">Contract Development Services</a></li> <li class="b_menu-flyout__item"><a href="/discovery-development/dosage-forms" class="b_menu-flyout__link">Dosage Forms</a></li> <li class="b_menu-flyout__item"><a href="/discovery-development/drug-delivery" class="b_menu-flyout__link">Drug Delivery</a></li> <li class="b_menu-flyout__item"><a href="/discovery-development/drug-discovery" class="b_menu-flyout__link">Drug Discovery</a></li> <li class="b_menu-flyout__item"><a href="/discovery-development/formulation" class="b_menu-flyout__link">Formulation</a></li> <li class="b_menu-flyout__item"><a href="/discovery-development/ingredients" class="b_menu-flyout__link">Ingredients</a></li> <li class="b_menu-flyout__item"><a href="/discovery-development/translational-science" class="b_menu-flyout__link">Translational Science</a></li> </ul> </div> <div class="b_flyout__column b_flyout__column--border"> <span class="b_flyout__title">Latest articles in Discovery & Development</span> <div class="b_flyout__grid b_flyout__grid--inner"> <div class="b_flyout__column b_flyout__column--category-teaser-item-1"> <a href="/discovery-development/breast-cancer-breakthrough" class="b_flyout__teaser"> <figure class="b_flyout__teaser-figure"> <picture><source srcset="/fileadmin/_processed_/c/4/csm_0225-205_Breast_Cancer_Teaser_f1269bb5e8.webp" media="(min-width: 1024px)" type="image/webp" /><source srcset="/fileadmin/_processed_/c/4/csm_0225-205_Breast_Cancer_Teaser_bd5af578fc.png" media="(min-width: 1024px)" /><source srcset="/fileadmin/_processed_/c/4/csm_0225-205_Breast_Cancer_Teaser_838bdc66c3.webp" media="(min-width: 1280px)" type="image/webp" /><source srcset="/fileadmin/_processed_/c/4/csm_0225-205_Breast_Cancer_Teaser_81561020bf.png" media="(min-width: 1280px)" /><source srcset="/fileadmin/_processed_/c/4/csm_0225-205_Breast_Cancer_Teaser_838bdc66c3.webp" type="image/webp" /><img class="b_flyout__teaser-image" src="/fileadmin/_processed_/c/4/csm_0225-205_Breast_Cancer_Teaser_81561020bf.png" width="266" height="167" loading="lazy" alt="" /></picture> </figure> Breast Cancer Breakthrough </a> </div> <div class="b_flyout__column b_flyout__column--category-teaser-item-2"> <a href="/discovery-development/examining-the-effectiveness-of-antidepressants" class="b_flyout__teaser"> <figure class="b_flyout__teaser-figure"> <picture><source srcset="/fileadmin/_processed_/1/f/csm_0225-004_AiNews_-_Depression_Teaser_d75907ec4b.webp" media="(min-width: 1024px)" type="image/webp" /><source srcset="/fileadmin/_processed_/1/f/csm_0225-004_AiNews_-_Depression_Teaser_c41e08f513.png" media="(min-width: 1024px)" /><source srcset="/fileadmin/_processed_/1/f/csm_0225-004_AiNews_-_Depression_Teaser_d1ba1d67ec.webp" media="(min-width: 1280px)" type="image/webp" /><source srcset="/fileadmin/_processed_/1/f/csm_0225-004_AiNews_-_Depression_Teaser_dc6f0137c6.png" media="(min-width: 1280px)" /><source srcset="/fileadmin/_processed_/1/f/csm_0225-004_AiNews_-_Depression_Teaser_d1ba1d67ec.webp" type="image/webp" /><img class="b_flyout__teaser-image" src="/fileadmin/_processed_/1/f/csm_0225-004_AiNews_-_Depression_Teaser_dc6f0137c6.png" width="266" height="167" loading="lazy" alt="" /></picture> </figure> Examining the Effectiveness of Antidepressants </a> </div> <div class="b_flyout__column b_flyout__column--menu-arrow-category"> <ul class="b_menu-flyout b_menu-flyout--arrow"> <li class="b_menu-flyout__item b_menu-flyout__item--category-list-item-1"> <a href="/discovery-development/breast-cancer-breakthrough" class="b_menu-flyout__link b_menu-flyout__link--arrow">Breast Cancer Breakthrough</a></li> <li class="b_menu-flyout__item b_menu-flyout__item--category-list-item-2"> <a href="/discovery-development/examining-the-effectiveness-of-antidepressants" class="b_menu-flyout__link b_menu-flyout__link--arrow">Examining the Effectiveness of Antidepressants</a></li> <li class="b_menu-flyout__item b_menu-flyout__item--category-list-item-3"> <a href="/discovery-development/venom-the-last-advance" class="b_menu-flyout__link b_menu-flyout__link--arrow">Venom: The Last Advance</a></li> <li class="b_menu-flyout__item b_menu-flyout__item--category-list-item-4"> <a href="/discovery-development/ai-in-oncology-the-bridge-between-the-patient-and-the-practice" class="b_menu-flyout__link b_menu-flyout__link--arrow">AI in Oncology: The Bridge Between the Patient and the Practice</a></li> <li class="b_menu-flyout__item b_menu-flyout__item--category-list-item-5"> <a href="/discovery-development/asking-the-right-questions-in-rd" class="b_menu-flyout__link b_menu-flyout__link--arrow">Asking the Right Questions in R&D</a></li> <li class="b_menu-flyout__item b_menu-flyout__item--category-list-item-6"> <a href="/discovery-development/the-trick-with-senolytics" class="b_menu-flyout__link b_menu-flyout__link--arrow">The Trick With Senolytics</a></li> </ul> <a href="/discovery-development" class="b_button b_button--flyout">All Articles</a> </div> </div> </div> </div> </div> </template> <template slot="flyoutCategory2"> <div class="b_header__container b_header__container--bottom"> <div class="b_flyout__grid"> <div class="b_flyout__column b_flyout__column--menu"> <span class="b_flyout__title">Topics</span> <ul class="b_menu-flyout"> <li class="b_menu-flyout__item"><a href="/manufacture/advanced-medicine" class="b_menu-flyout__link">Advanced Medicine</a></li> <li class="b_menu-flyout__item"><a href="/manufacture/contract-manufacturing-services" class="b_menu-flyout__link">Contract Manufacturing Services</a></li> <li class="b_menu-flyout__item"><a href="/manufacture/bioprocessing-single-use-systems" class="b_menu-flyout__link">Bioprocessing - Single Use Systems</a></li> <li class="b_menu-flyout__item"><a href="/manufacture/bioprocessing-upstream-downstream" class="b_menu-flyout__link">Bioprocessing - Upstream & Downstream</a></li> <li class="b_menu-flyout__item"><a href="/manufacture/biosimilars" class="b_menu-flyout__link">Biosimilars</a></li> <li class="b_menu-flyout__item"><a href="/manufacture/facilities" class="b_menu-flyout__link">Facilities</a></li> <li class="b_menu-flyout__item"><a href="/manufacture/packaging" class="b_menu-flyout__link">Packaging</a></li> <li class="b_menu-flyout__item"><a href="/manufacture/process-control" class="b_menu-flyout__link">Process Control</a></li> <li class="b_menu-flyout__item"><a href="/manufacture/quality-compliance" class="b_menu-flyout__link">Quality & Compliance</a></li> <li class="b_menu-flyout__item"><a href="/manufacture/small-molecules" class="b_menu-flyout__link">Small Molecules</a></li> <li class="b_menu-flyout__item"><a href="/manufacture/technology-and-equipment" class="b_menu-flyout__link">Technology and Equipment</a></li> <li class="b_menu-flyout__item"><a href="/manufacture/vaccines" class="b_menu-flyout__link">Vaccines</a></li> </ul> </div> <div class="b_flyout__column b_flyout__column--border"> <span class="b_flyout__title">Latest articles in Manufacture</span> <div class="b_flyout__grid b_flyout__grid--inner"> <div class="b_flyout__column b_flyout__column--category-teaser-item-1"> <a href="/manufacture/the-era-of-antibody-20" class="b_flyout__teaser"> <figure class="b_flyout__teaser-figure"> <picture><source srcset="/fileadmin/_processed_/f/8/csm_0225-403_AnniversaryFeature_-_Merck_AP_Teaser_1_7b0251687b.webp" media="(min-width: 1024px)" type="image/webp" /><source srcset="/fileadmin/_processed_/f/8/csm_0225-403_AnniversaryFeature_-_Merck_AP_Teaser_1_fb4ed919df.png" media="(min-width: 1024px)" /><source srcset="/fileadmin/_processed_/f/8/csm_0225-403_AnniversaryFeature_-_Merck_AP_Teaser_1_70fdf34ce8.webp" media="(min-width: 1280px)" type="image/webp" /><source srcset="/fileadmin/_processed_/f/8/csm_0225-403_AnniversaryFeature_-_Merck_AP_Teaser_1_8c78343fca.png" media="(min-width: 1280px)" /><source srcset="/fileadmin/_processed_/f/8/csm_0225-403_AnniversaryFeature_-_Merck_AP_Teaser_1_70fdf34ce8.webp" type="image/webp" /><img class="b_flyout__teaser-image" src="/fileadmin/_processed_/f/8/csm_0225-403_AnniversaryFeature_-_Merck_AP_Teaser_1_8c78343fca.png" width="266" height="167" loading="lazy" alt="" /></picture> </figure> The Era of Antibody 2.0 </a> </div> <div class="b_flyout__column b_flyout__column--category-teaser-item-2"> <a href="/manufacture/integrating-technology-and-robotics-in-cgt-manufacturing" class="b_flyout__teaser"> <figure class="b_flyout__teaser-figure"> <picture><source srcset="/fileadmin/_processed_/6/2/csm_0225-504_Cell_and_Gene_Therapy_-_JONES_CELLULAR_ORIGINS_Teaser_82fd0658a1.webp" media="(min-width: 1024px)" type="image/webp" /><source srcset="/fileadmin/_processed_/6/2/csm_0225-504_Cell_and_Gene_Therapy_-_JONES_CELLULAR_ORIGINS_Teaser_950b0af7ad.png" media="(min-width: 1024px)" /><source srcset="/fileadmin/_processed_/6/2/csm_0225-504_Cell_and_Gene_Therapy_-_JONES_CELLULAR_ORIGINS_Teaser_19b4cf6c20.webp" media="(min-width: 1280px)" type="image/webp" /><source srcset="/fileadmin/_processed_/6/2/csm_0225-504_Cell_and_Gene_Therapy_-_JONES_CELLULAR_ORIGINS_Teaser_19ece89170.png" media="(min-width: 1280px)" /><source srcset="/fileadmin/_processed_/6/2/csm_0225-504_Cell_and_Gene_Therapy_-_JONES_CELLULAR_ORIGINS_Teaser_19b4cf6c20.webp" type="image/webp" /><img class="b_flyout__teaser-image" src="/fileadmin/_processed_/6/2/csm_0225-504_Cell_and_Gene_Therapy_-_JONES_CELLULAR_ORIGINS_Teaser_19ece89170.png" width="266" height="167" loading="lazy" alt="" /></picture> </figure> Integrating Technology and Robotics in CGT Manufacturing </a> </div> <div class="b_flyout__column b_flyout__column--menu-arrow-category"> <ul class="b_menu-flyout b_menu-flyout--arrow"> <li class="b_menu-flyout__item b_menu-flyout__item--category-list-item-1"> <a href="/manufacture/the-era-of-antibody-20" class="b_menu-flyout__link b_menu-flyout__link--arrow">The Era of Antibody 2.0</a></li> <li class="b_menu-flyout__item b_menu-flyout__item--category-list-item-2"> <a href="/manufacture/integrating-technology-and-robotics-in-cgt-manufacturing" class="b_menu-flyout__link b_menu-flyout__link--arrow">Integrating Technology and Robotics in CGT Manufacturing</a></li> <li class="b_menu-flyout__item b_menu-flyout__item--category-list-item-3"> <a href="/manufacture/vial-wars" class="b_menu-flyout__link b_menu-flyout__link--arrow">Vial Wars</a></li> <li class="b_menu-flyout__item b_menu-flyout__item--category-list-item-4"> <a href="/manufacture/2025-predictions-for-rna-therapeutics" class="b_menu-flyout__link b_menu-flyout__link--arrow">2025 Predictions for RNA Therapeutics</a></li> <li class="b_menu-flyout__item b_menu-flyout__item--category-list-item-5"> <a href="/manufacture/using-ai-to-conquer-the-undruggable" class="b_menu-flyout__link b_menu-flyout__link--arrow">Using AI to Conquer the Undruggable</a></li> <li class="b_menu-flyout__item b_menu-flyout__item--category-list-item-6"> <a href="/manufacture/digital-twins-in-car-t-manufacturing" class="b_menu-flyout__link b_menu-flyout__link--arrow">Digital Twins in CAR-T Manufacturing</a></li> </ul> <a href="/manufacture" class="b_button b_button--flyout">All Articles</a> </div> </div> </div> </div> </div> </template> <template slot="flyoutCategory3"> <div class="b_header__container b_header__container--bottom"> <div class="b_flyout__grid"> <div class="b_flyout__column b_flyout__column--menu"> <span class="b_flyout__title">Topics</span> <ul class="b_menu-flyout"> <li class="b_menu-flyout__item"><a href="/business-regulation/business-practice" class="b_menu-flyout__link">Business Practice</a></li> <li class="b_menu-flyout__item"><a href="/business-regulation/digital-technologies" class="b_menu-flyout__link">Digital Technologies</a></li> <li class="b_menu-flyout__item"><a href="/business-regulation/marketing" class="b_menu-flyout__link">Marketing</a></li> <li class="b_menu-flyout__item"><a href="/business-regulation/profession" class="b_menu-flyout__link">Profession</a></li> <li class="b_menu-flyout__item"><a href="/business-regulation/standards-regulation" class="b_menu-flyout__link">Standards & Regulation</a></li> <li class="b_menu-flyout__item"><a href="/business-regulation/supply-chain" class="b_menu-flyout__link">Supply Chain</a></li> <li class="b_menu-flyout__item"><a href="/business-regulation/trends-forecasts" class="b_menu-flyout__link">Trends & Forecasts</a></li> <li class="b_menu-flyout__item"><a href="/business-regulation/covid-19" class="b_menu-flyout__link">COVID-19</a></li> </ul> </div> <div class="b_flyout__column b_flyout__column--border"> <span class="b_flyout__title">Latest articles in Business & Regulation</span> <div class="b_flyout__grid b_flyout__grid--inner"> <div class="b_flyout__column b_flyout__column--category-teaser-item-1"> <a href="/business-regulation/researchers-respond-to-nih-funding-cuts" class="b_flyout__teaser"> <figure class="b_flyout__teaser-figure"> <picture><source srcset="/fileadmin/_processed_/1/0/csm_0225-005_USA_Teaser_c5e24eac0d.webp" media="(min-width: 1024px)" type="image/webp" /><source srcset="/fileadmin/_processed_/1/0/csm_0225-005_USA_Teaser_c08ff4075b.png" media="(min-width: 1024px)" /><source srcset="/fileadmin/_processed_/1/0/csm_0225-005_USA_Teaser_63a25e50e1.webp" media="(min-width: 1280px)" type="image/webp" /><source srcset="/fileadmin/_processed_/1/0/csm_0225-005_USA_Teaser_457137ac10.png" media="(min-width: 1280px)" /><source srcset="/fileadmin/_processed_/1/0/csm_0225-005_USA_Teaser_63a25e50e1.webp" type="image/webp" /><img class="b_flyout__teaser-image" src="/fileadmin/_processed_/1/0/csm_0225-005_USA_Teaser_457137ac10.png" width="266" height="167" loading="lazy" alt="" /></picture> </figure> Researchers Respond to NIH Funding Cuts </a> </div> <div class="b_flyout__column b_flyout__column--category-teaser-item-2"> <a href="/business-regulation/the-secret-to-being-a-good-employer" class="b_flyout__teaser"> <figure class="b_flyout__teaser-figure"> <picture><source srcset="/fileadmin/_processed_/f/9/csm_0225-602_Business_-_VENTURA_HOVIONE_Teaser_892c07bee1.webp" media="(min-width: 1024px)" type="image/webp" /><source srcset="/fileadmin/_processed_/f/9/csm_0225-602_Business_-_VENTURA_HOVIONE_Teaser_e4313bb638.png" media="(min-width: 1024px)" /><source srcset="/fileadmin/_processed_/f/9/csm_0225-602_Business_-_VENTURA_HOVIONE_Teaser_d109cecd6a.webp" media="(min-width: 1280px)" type="image/webp" /><source srcset="/fileadmin/_processed_/f/9/csm_0225-602_Business_-_VENTURA_HOVIONE_Teaser_944f9ce89a.png" media="(min-width: 1280px)" /><source srcset="/fileadmin/_processed_/f/9/csm_0225-602_Business_-_VENTURA_HOVIONE_Teaser_d109cecd6a.webp" type="image/webp" /><img class="b_flyout__teaser-image" src="/fileadmin/_processed_/f/9/csm_0225-602_Business_-_VENTURA_HOVIONE_Teaser_944f9ce89a.png" width="266" height="167" loading="lazy" alt="" /></picture> </figure> The Secret to Being a Good Employer </a> </div> <div class="b_flyout__column b_flyout__column--menu-arrow-category"> <ul class="b_menu-flyout b_menu-flyout--arrow"> <li class="b_menu-flyout__item b_menu-flyout__item--category-list-item-1"> <a href="/business-regulation/researchers-respond-to-nih-funding-cuts" class="b_menu-flyout__link b_menu-flyout__link--arrow">Researchers Respond to NIH Funding Cuts</a></li> <li class="b_menu-flyout__item b_menu-flyout__item--category-list-item-2"> <a href="/business-regulation/the-secret-to-being-a-good-employer" class="b_menu-flyout__link b_menu-flyout__link--arrow">The Secret to Being a Good Employer</a></li> <li class="b_menu-flyout__item b_menu-flyout__item--category-list-item-3"> <a href="/business-regulation/trumps-tariffs" class="b_menu-flyout__link b_menu-flyout__link--arrow">Trump’s Tariffs</a></li> <li class="b_menu-flyout__item b_menu-flyout__item--category-list-item-4"> <a href="/business-regulation/sanofis-push-for-pricing-flexibility-in-the-uk" class="b_menu-flyout__link b_menu-flyout__link--arrow">Sanofi’s Push for Pricing Flexibility in the UK</a></li> <li class="b_menu-flyout__item b_menu-flyout__item--category-list-item-5"> <a href="/business-regulation/robert-f-kennedy-jr-nomination-advances" class="b_menu-flyout__link b_menu-flyout__link--arrow">Robert F. Kennedy Jr Nomination Advances</a></li> <li class="b_menu-flyout__item b_menu-flyout__item--category-list-item-6"> <a href="/discovery-development/maintaining-momentum" class="b_menu-flyout__link b_menu-flyout__link--arrow">Maintaining Momentum</a></li> </ul> <a href="/business-regulation" class="b_button b_button--flyout">All Articles</a> </div> </div> </div> </div> </div> </template> <template slot="flyoutIssue"> <div class="b_header__container b_header__container--bottom"> <div class="b_flyout__grid"> <div class="b_flyout__column b_flyout__column--cover"> <picture><source srcset="/fileadmin/_processed_/d/6/csm_1224_TMM_Nov_Dec_b4a61ad774.webp" type="image/webp" /><img class="b_issuelist__image" src="/fileadmin/_processed_/d/6/csm_1224_TMM_Nov_Dec_5c62124544.png" width="162" height="206" loading="lazy" alt="" /></picture> </div> <div class="b_flyout__column b_flyout__column--issue-article"> <span class="b_flyout__title"> Latest Issue <span class="b_flyout__subtitle">December 2024</span> </span> <ul class="b_menu-flyout b_menu-flyout--arrow"> <li class="b_menu-flyout__item b_menu-flyout__item--issue-list-item-1"><a href="/business-regulation/sustainability-modern-supply-chains-and-the-pharma-industry" class="b_menu-flyout__link b_menu-flyout__link--arrow">The Intersection of Sustainability</a></li> <li class="b_menu-flyout__item b_menu-flyout__item--issue-list-item-2"><a href="/discovery-development/boosting-vaccine-stability-with-gelatin" class="b_menu-flyout__link b_menu-flyout__link--arrow">Boosting Vaccine Stability with Gelatin</a></li> <li class="b_menu-flyout__item b_menu-flyout__item--issue-list-item-3"><a href="/discovery-development/lets-make-a-real-difference-in-cancer" class="b_menu-flyout__link b_menu-flyout__link--arrow">Let’s Make a Real Difference in Cancer</a></li> </ul> <a href="/issues/1224" class="b_button">All Articles of the latest Issue</a> </div> <div class="b_flyout__column b_flyout__column--border b_flyout__column--issue-archive"> <span class="b_flyout__title">Issue Archive</span> <ul class="b_menu-flyout b_menu-flyout--arrow"> <li class="b_menu-flyout__item"><a href="/issues/1024" class="b_menu-flyout__link b_menu-flyout__link--arrow">October 2024</a></li> <li class="b_menu-flyout__item"><a href="/issues/0824" class="b_menu-flyout__link b_menu-flyout__link--arrow">August 2024</a></li> <li class="b_menu-flyout__item"><a href="/issues/0624" class="b_menu-flyout__link b_menu-flyout__link--arrow">June 2024</a></li> <li class="b_menu-flyout__item"><a href="/issues/0424" class="b_menu-flyout__link b_menu-flyout__link--arrow">April 2024</a></li> </ul> <a class="b_button b_button--secondary" href="/issues">Complete Issue Archive</a> </div> </div> </div> </template> <template slot="flyoutProductProfiles"> <div class="b_header__container b_header__container--bottom"> <div class="b_flyout__grid"> <div class="b_flyout__column"> <span class="b_flyout__title">Latest Product Profiles</span> <div class="b_flyout__grid b_flyout__grid--inner"> <div class="b_flyout__column b_flyout__column--productprofile-teaser-item-1"> <a href="/product-profiles/trypsinnexr-is-a-new-animal-free-trypsin-in-excipient-gmp-quality" class="b_flyout__teaser"> <figure class="b_flyout__teaser-figure"> <picture><source srcset="/fileadmin/_processed_/1/1/csm_TrypsiNNex_652x328_04eb84dd61.webp" media="(min-width: 1024px)" type="image/webp" /><source srcset="/fileadmin/_processed_/1/1/csm_TrypsiNNex_652x328_80bc4bf0e7.jpg" media="(min-width: 1024px)" /><source srcset="/fileadmin/_processed_/1/1/csm_TrypsiNNex_652x328_adce313b1c.webp" type="image/webp" /><img class="b_flyout__teaser-image" src="/fileadmin/_processed_/1/1/csm_TrypsiNNex_652x328_9fea9c4908.jpg" width="186" height="117" loading="lazy" alt="" /></picture> <figcaption class="b_flyout__teaser-companybanner"> <picture><source srcset="/fileadmin/_processed_/f/8/csm_Novo-Nordisk-logo_2fbb672712.webp" type="image/webp" /><img class="b_flyout__teaser-companybanner-logo" src="/fileadmin/_processed_/f/8/csm_Novo-Nordisk-logo_a9abe139b5.jpg" width="140" height="35" loading="lazy" alt="" /></picture> </figcaption> </figure> TrypsiNNex® is a new animal-free trypsin in Excipient GMP quality </a> </div> <div class="b_flyout__column b_flyout__column--productprofile-teaser-item-2"> <a href="/product-profiles/mobiusr-breez-microbioreactor-the-smallest-automated-high-throughput-bioreactor-yet-merck" class="b_flyout__teaser"> <figure class="b_flyout__teaser-figure"> <picture><source srcset="/fileadmin/_processed_/a/4/csm_Mobius_Breeze_652x328px_b4565cf389.webp" media="(min-width: 1024px)" type="image/webp" /><source srcset="/fileadmin/_processed_/a/4/csm_Mobius_Breeze_652x328px_c5ed4c404b.png" media="(min-width: 1024px)" /><source srcset="/fileadmin/_processed_/a/4/csm_Mobius_Breeze_652x328px_45bcc54d02.webp" type="image/webp" /><img class="b_flyout__teaser-image" src="/fileadmin/_processed_/a/4/csm_Mobius_Breeze_652x328px_5f1a2dcc35.png" width="186" height="117" loading="lazy" alt="" /></picture> <figcaption class="b_flyout__teaser-companybanner"> <picture><source srcset="/fileadmin/_processed_/f/1/csm_merck_logo_29d4e26eaf.webp" type="image/webp" /><img class="b_flyout__teaser-companybanner-logo" src="/fileadmin/_processed_/f/1/csm_merck_logo_b8408b3f56.png" width="122" height="35" loading="lazy" alt="" /></picture> </figcaption> </figure> Mobius® Breez Microbioreactor: The Smallest, Automated, High-Throughput Bioreactor Yet </a> </div> <div class="b_flyout__column b_flyout__column--productprofile-teaser-item-3"> <a href="/product-profiles/the-pin-mill-pmv-320-protecting-users-and-apis" class="b_flyout__teaser"> <figure class="b_flyout__teaser-figure"> <picture><source srcset="/fileadmin/_processed_/4/1/csm_1122-900-INN-Frewitt_Teaser_5dad242275.webp" media="(min-width: 1024px)" type="image/webp" /><source srcset="/fileadmin/_processed_/4/1/csm_1122-900-INN-Frewitt_Teaser_a53d1a6415.png" media="(min-width: 1024px)" /><source srcset="/fileadmin/_processed_/4/1/csm_1122-900-INN-Frewitt_Teaser_f3217552f1.webp" type="image/webp" /><img class="b_flyout__teaser-image" src="/fileadmin/_processed_/4/1/csm_1122-900-INN-Frewitt_Teaser_b3f3f50307.png" width="186" height="117" loading="lazy" alt="" /></picture> <figcaption class="b_flyout__teaser-companybanner"> <picture><source srcset="/fileadmin/_processed_/6/2/csm_Frewitt-logo_8596528f82.webp" type="image/webp" /><img class="b_flyout__teaser-companybanner-logo" src="/fileadmin/_processed_/6/2/csm_Frewitt-logo_6121f93a90.jpg" width="124" height="35" loading="lazy" alt="" /></picture> </figcaption> </figure> The Pin Mill PMV-320: Protecting Users and API’s </a> </div> <div class="b_flyout__column b_flyout__column--menu-arrow-productprofile"> <ul class="b_menu-flyout b_menu-flyout--arrow"> <li class="b_menu-flyout__item b_menu-flyout__item--productprofile-list-item-1"> <a href="/product-profiles/trypsinnexr-is-a-new-animal-free-trypsin-in-excipient-gmp-quality" class="b_menu-flyout__link b_menu-flyout__link--arrow">TrypsiNNex® is a new animal-free trypsin in Excipient GMP quality</a></li> <li class="b_menu-flyout__item b_menu-flyout__item--productprofile-list-item-2"> <a href="/product-profiles/mobiusr-breez-microbioreactor-the-smallest-automated-high-throughput-bioreactor-yet-merck" class="b_menu-flyout__link b_menu-flyout__link--arrow">Mobius® Breez Microbioreactor: The Smallest, Automated, High-Throughput Bioreactor Yet</a></li> <li class="b_menu-flyout__item b_menu-flyout__item--productprofile-list-item-3"> <a href="/product-profiles/the-pin-mill-pmv-320-protecting-users-and-apis" class="b_menu-flyout__link b_menu-flyout__link--arrow">The Pin Mill PMV-320: Protecting Users and API’s</a></li> <li class="b_menu-flyout__item b_menu-flyout__item--productprofile-list-item-4"> <a href="/product-profiles/flexsafer-pro-mixer-makes-cgmp-bioprocessing-fast-flexible" class="b_menu-flyout__link b_menu-flyout__link--arrow">Flexsafe® Pro Mixer Makes cGMP Bioprocessing Fast & Flexible</a></li> <li class="b_menu-flyout__item b_menu-flyout__item--productprofile-list-item-5"> <a href="/product-profiles/4cellr-nutri-t-media" class="b_menu-flyout__link b_menu-flyout__link--arrow">4Cell<sup>®</sup> Nutri-T Media</a></li> </ul> <a class="b_button b_button--flyout" href="/product-profiles">All Product Profiles</a> </div> </div> </div> </div> </div> </template> <template slot="flyoutAppnotes"> <div class="b_header__container b_header__container--bottom"> <div class="b_flyout__grid"> <div class="b_flyout__column"> <span class="b_flyout__title">Latest White Papers</span> <div class="b_flyout__grid b_flyout__grid--inner"> <div class="b_flyout__column b_flyout__column--appnote-teaser-item-1"> <a href="/white-papers/viral-safety-and-viral-clearance-summit-takeaways" class="b_flyout__teaser"> <figure class="b_flyout__teaser-figure"> <picture><source srcset="/fileadmin/_processed_/2/a/csm_Charles_River_Teaser_cf3ff44a5f.webp" media="(min-width: 1024px)" type="image/webp" /><source srcset="/fileadmin/_processed_/2/a/csm_Charles_River_Teaser_7a423fe0ca.png" media="(min-width: 1024px)" /><source srcset="/fileadmin/_processed_/2/a/csm_Charles_River_Teaser_25ded233cf.webp" type="image/webp" /><img class="b_flyout__teaser-image" src="/fileadmin/_processed_/2/a/csm_Charles_River_Teaser_ff6e7e4ded.png" width="186" height="117" loading="lazy" alt="" /></picture> </figure> Viral Safety and Viral Clearance Summit Takeaways </a> </div> <div class="b_flyout__column b_flyout__column--appnote-teaser-item-2"> <a href="/white-papers/single-ingredient-optimization-supports-the-expansion-of-pluripotent-stem-cells" class="b_flyout__teaser"> <figure class="b_flyout__teaser-figure"> <picture><source srcset="/fileadmin/_processed_/b/9/csm_Application_note_652x328px_c9da9b637c.webp" media="(min-width: 1024px)" type="image/webp" /><source srcset="/fileadmin/_processed_/b/9/csm_Application_note_652x328px_df1f10e380.jpg" media="(min-width: 1024px)" /><source srcset="/fileadmin/_processed_/b/9/csm_Application_note_652x328px_39b600fe09.webp" type="image/webp" /><img class="b_flyout__teaser-image" src="/fileadmin/_processed_/b/9/csm_Application_note_652x328px_83aaa758f3.jpg" width="186" height="117" loading="lazy" alt="" /></picture> </figure> Single ingredient optimization supports the expansion of pluripotent stem cells </a> </div> <div class="b_flyout__column b_flyout__column--appnote-teaser-item-3"> <a href="/white-papers/nitrosamines-risk-mitigation-the-critical-role-of-excipients-and-supplier-qualification" class="b_flyout__teaser"> <figure class="b_flyout__teaser-figure"> <picture><source srcset="/fileadmin/_processed_/0/2/csm_DFE-Pharma-white-paper-1122-teaser_dfbed7cbc5.webp" media="(min-width: 1024px)" type="image/webp" /><source srcset="/fileadmin/_processed_/0/2/csm_DFE-Pharma-white-paper-1122-teaser_53edff2932.png" media="(min-width: 1024px)" /><source srcset="/fileadmin/_processed_/0/2/csm_DFE-Pharma-white-paper-1122-teaser_3951bfe60f.webp" type="image/webp" /><img class="b_flyout__teaser-image" src="/fileadmin/_processed_/0/2/csm_DFE-Pharma-white-paper-1122-teaser_3cf5710e86.png" width="186" height="117" loading="lazy" alt="" /></picture> </figure> Nitrosamines Risk Mitigation: The critical role of excipients and supplier qualification </a> </div> <div class="b_flyout__column b_flyout__column--menu-arrow-appnotes"> <ul class="b_menu-flyout b_menu-flyout--arrow"> <li class="b_menu-flyout__item b_menu-flyout__item--appnote-list-item-1"> <a href="/white-papers/viral-safety-and-viral-clearance-summit-takeaways" class="b_menu-flyout__link b_menu-flyout__link--arrow">Viral Safety and Viral Clearance Summit Takeaways</a></li> <li class="b_menu-flyout__item b_menu-flyout__item--appnote-list-item-2"> <a href="/white-papers/single-ingredient-optimization-supports-the-expansion-of-pluripotent-stem-cells" class="b_menu-flyout__link b_menu-flyout__link--arrow">Single ingredient optimization supports the expansion of pluripotent stem cells</a></li> <li class="b_menu-flyout__item b_menu-flyout__item--appnote-list-item-3"> <a href="/white-papers/nitrosamines-risk-mitigation-the-critical-role-of-excipients-and-supplier-qualification" class="b_menu-flyout__link b_menu-flyout__link--arrow">Nitrosamines Risk Mitigation: The critical role of excipients and supplier qualification</a></li> <li class="b_menu-flyout__item b_menu-flyout__item--appnote-list-item-4"> <a href="/white-papers/ploughsharer-mixer-for-batch-operation-in-pharmaceutical-production-well-established-all-rounder" class="b_menu-flyout__link b_menu-flyout__link--arrow">Ploughshare® Mixer for batch operation in pharmaceutical production: well-established all-rounder</a></li> <li class="b_menu-flyout__item b_menu-flyout__item--appnote-list-item-5"> <a href="/white-papers/accelerate-your-cell-line-development-process-for-commercial-production" class="b_menu-flyout__link b_menu-flyout__link--arrow">Accelerate Your Cell Line Development Process for Commercial Production</a></li> </ul> <a class="b_button b_button--flyout" href="/white-papers">All White Papers</a> </div> </div> </div> </div> </div> </template> <template slot="flyoutPowerlists"> <div class="b_header__container b_header__container--bottom"> <div class="b_flyout__grid"> <div class="b_flyout__column b_flyout__column--cover"> <picture><source srcset="/fileadmin/_processed_/e/7/csm_PL_2022_f0d089317e.webp" type="image/webp" /><img src="/fileadmin/_processed_/e/7/csm_PL_2022_47d25b08a4.png" width="170" height="170" loading="lazy" alt="" /></picture> </div> <div class="b_flyout__column b_flyout__column--powerlist-current"> <span class="b_flyout__title"> Find out more <span class="b_flyout__subtitle">The Power List 2022</span> </span> <p class="b_flyout__text"> The Power List 2022 focuses on the top 10 VIPs in three key categories of medicine making </p> <a class="b_button" href="/awards/power-list/2022">Find out more</a> </div> <div class="b_flyout__column b_flyout__column--border b_flyout__column--powerlist-past"> <span class="b_flyout__title"> Find out more <a class="b_flyout__subtitle b_flyout__subtitle--arrow" href="/power-list/2021"> The Power List 2021 </a> </span> <span class="b_flyout__title"> The Power List 2020 <a class="b_flyout__subtitle b_flyout__subtitle--arrow" href="/power-list/2020"> The Power List 2020 </a> </span> <span class="b_flyout__title"> The Power List 2019 <a class="b_flyout__subtitle b_flyout__subtitle--arrow" href="/power-list/2019"> The Power List 2019 </a> </span> <a class="b_button b_button--secondary" href="/power-list">All Power Lists </a> </div> </div> </div> </template> <template slot="flyoutAwards"> <div class="b_header__container b_header__container--bottom"> <div class="b_flyout__grid"> <div class="b_flyout__column b_flyout__column--cover"> <picture><source srcset="/fileadmin/_processed_/f/6/csm_0225-402_Feature_-_COTYA_Teaser_3df46a5449.webp" type="image/webp" /><img src="/fileadmin/_processed_/f/6/csm_0225-402_Feature_-_COTYA_Teaser_4d8aad1f6d.png" width="170" height="114" loading="lazy" alt="" /></picture> </div> <div class="b_flyout__column b_flyout__column--powerlist-current"> <span class="b_flyout__title"> Read more <span class="b_flyout__subtitle">The Company Of The Year 2025</span> </span> <p class="b_flyout__text"> The 2025 winners are here! Novo Nordisk takes the top spot in Big Pharma, while Merck leads in bioprocessing solutions. </p> <a class="b_button" href="/awards/the-company-of-the-year-2025">Read more</a> </div> <div class="b_flyout__column b_flyout__column--border b_flyout__column--powerlist-past"> <span class="b_flyout__title"> Find out more <a class="b_flyout__subtitle b_flyout__subtitle--arrow" href="/awards/power-list/2024"> The Power List 2024 </a> </span> <span class="b_flyout__title"> Read more <a class="b_flyout__subtitle b_flyout__subtitle--arrow" href="/awards/the-company-of-the-year-2024"> The Company Of The Year 2024 </a> </span> <span class="b_flyout__title"> Find out more <a class="b_flyout__subtitle b_flyout__subtitle--arrow" href="/awards/the-innovation-awards"> The Innovation Awards </a> </span> <a class="b_button b_button--secondary" href="/awards">All Awards </a> </div> </div> </div> </template> </main-menu-flyout> </header> <div class="b_nlreg__sidebar"> <a href="https://themedicinemaker.com/newsletter-registration?utm_source=website&utm_medium=display&utm_campaign=nl_button" target="_blank" class="b_nlreg__link b_nlreg__link--sidebar"> <span class="b_nlreg__sidebar-label">Subscribe to Newsletter</span> </a> </div> <main id="bJS_main" class="b_main b_main--article b_main--hasSubmenu "> <vue-registration-complete headline="Complete your registration." text="To gain access to all our White Papers and Product Profiles, we would like some additional information." button="Edit your Information" profile_url="" information_url="" :user="user" > <template slot="registrationFinished"> <span class="b_banner__headline">Registration Completed</span> <div class="b_banner__text"> Congratulations! You now have unlimited access to all articles from The Medicine Maker. Complete your profile at your earliest convenience to unlock the rest of your benefits:<br> <ul> <li>relevant and personalised updates about your field</li> <li>access to White Papers/product profiles</li> <li>digital magazine subscription</li> </ul> </div> </template> </vue-registration-complete> <span class="b_category__container b_category__container--article"> <a href="/manufacture" class="b_category b_category--color-2 b_category--title b_category--has-topic "> Manufacture </a> <a class="b_category b_category--color-2 b_category--topic " href="/manufacture/advanced-medicine"> Advanced Medicine </a> </span> <div class="b_main__grid b_main__grid--article"> <div class="b_main__column-sharing"> <vue-affix relative-element-selector=".b_main__column-sharing" :offset="{top: 120, bottom: 0}"> <ul class="b_menu-share "> <li class="b_menu-share__item"> <vue-bookmark :uid="12047" :user="user" :is-share="true"></vue-bookmark> </li> <li class="b_menu-share__item"> <a href="/cdn-cgi/l/email-protection#e7d89492858d828493dab38f8e94c2d5d78a8e808f93c2d5d78e89938295829493c2d5d79e8892c18588839eda8f93939794c2d4a6c2d5a1c2d5a1938f828a82838e848e89828a868c8295c984888ac2d5a18a86899281868493929582c2d5a1938f82ca949386939294ca969288ca8881ca888b8e80888992848b8288938e838294ca8e94ca898893ca938f82ca819293929582" class="b_menu-share__link b_menu-share__link--email" target="_blank" rel="noopener" title="Share this article by email"></a> </li> <li class="b_menu-share__item"> <a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fthemedicinemaker.com%2Fmanufacture%2Fthe-status-quo-of-oligonucleotides-is-not-the-future" class="b_menu-share__link b_menu-share__link--facebook" target="_blank" rel="noopener" title="Share this article on Facebook"></a> </li> <li class="b_menu-share__item"> <a href="https://www.linkedin.com/shareArticle?url=https%3A%2F%2Fthemedicinemaker.com%2Fmanufacture%2Fthe-status-quo-of-oligonucleotides-is-not-the-future" class="b_menu-share__link b_menu-share__link--linkedin" target="_blank" rel="noopener" title="Share this article on LinkedIn"></a> </li> <li class="b_menu-share__item"> <a class="b_menu-share__link b_menu-share__link--twitter-x" href="https://x.com/share?url=https%3A%2F%2Fthemedicinemaker.com%2Fmanufacture%2Fthe-status-quo-of-oligonucleotides-is-not-the-future" target="_blank" rel="noopener" title="Share this article on X"></a> </li> <li class="b_menu-share__item"> <a class="b_menu-share__link b_menu-share__link--doximity" href="https://www.doximity.com/conversations/new?url=https%3A%2F%2Fthemedicinemaker.com%2Fmanufacture%2Fthe-status-quo-of-oligonucleotides-is-not-the-future" target="_blank" rel="noopener" title="Share this article on Doximity"></a> </a> </li> <li class="b_menu-share__item"> <a href="javascript:window.print()" class="b_menu-share__link b_menu-share__link--print" title="Print this article"></a> </li> </ul> </vue-affix> </div> <div class="b_main__grid-container"> <div class="b_article__header b_article__header--articlepage"> <h1 class="b_article__headline b_article__headline--h1">The Status Quo of Oligonucleotides Is Not the Future</h1> <p class="b_article__subline b_article__subline--h2">The science of oligonucleotides is advancing, and advanced manufacturing techniques are needed to optimize their impact</p> <p class="b_article__info"> <time datetime="2024-11-15"> 11/15/2024 </time> | 7 min read | <a class="b_article__infolink" href="/search?q=%2A&tx_solr%5Bfilter%5D%5B0%5D=assetType%3AInterview">Interview</a> </p> <p class="b_article__sponsor"> <span class="b_article__sponsor-label">sponsored by</span> <a href="/companies/asahi-kasei-bioprocess" target="_blank" class="b_article__sponsor-link">Asahi Kasei Bioprocess</a> </p> <ul class="b_menu-share b_menu-share--xs-only"> <li class="b_menu-share__item"> <vue-bookmark :uid="12047" :user="user" :is-share="true"></vue-bookmark> </li> <li class="b_menu-share__item"> <a href="/cdn-cgi/l/email-protection#95aae6e0f7fff0f6e1a8c1fdfce6b0a7a5f8fcf2fde1b0a7a5fcfbe1f0e7f0e6e1b0a7a5ecfae0b3f7faf1eca8fde1e1e5e6b0a6d4b0a7d3b0a7d3e1fdf0f8f0f1fcf6fcfbf0f8f4fef0e7bbf6faf8b0a7d3f8f4fbe0f3f4f6e1e0e7f0b0a7d3e1fdf0b8e6e1f4e1e0e6b8e4e0fab8faf3b8faf9fcf2fafbe0f6f9f0fae1fcf1f0e6b8fce6b8fbfae1b8e1fdf0b8f3e0e1e0e7f0" class="b_menu-share__link b_menu-share__link--email" target="_blank" rel="noopener" title="Share this article by email"></a> </li> <li class="b_menu-share__item"> <a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fthemedicinemaker.com%2Fmanufacture%2Fthe-status-quo-of-oligonucleotides-is-not-the-future" class="b_menu-share__link b_menu-share__link--facebook" target="_blank" rel="noopener" title="Share this article on Facebook"></a> </li> <li class="b_menu-share__item"> <a href="https://www.linkedin.com/shareArticle?url=https%3A%2F%2Fthemedicinemaker.com%2Fmanufacture%2Fthe-status-quo-of-oligonucleotides-is-not-the-future" class="b_menu-share__link b_menu-share__link--linkedin" target="_blank" rel="noopener" title="Share this article on LinkedIn"></a> </li> <li class="b_menu-share__item"> <a class="b_menu-share__link b_menu-share__link--twitter-x" href="https://x.com/share?url=https%3A%2F%2Fthemedicinemaker.com%2Fmanufacture%2Fthe-status-quo-of-oligonucleotides-is-not-the-future" target="_blank" rel="noopener" title="Share this article on X"></a> </li> <li class="b_menu-share__item"> <a class="b_menu-share__link b_menu-share__link--doximity" href="https://www.doximity.com/conversations/new?url=https%3A%2F%2Fthemedicinemaker.com%2Fmanufacture%2Fthe-status-quo-of-oligonucleotides-is-not-the-future" target="_blank" rel="noopener" title="Share this article on Doximity"></a> </a> </li> <li class="b_menu-share__item"> <a href="javascript:window.print()" class="b_menu-share__link b_menu-share__link--print" title="Print this article"></a> </li> </ul> </div> <div class="b_main__column-content b_main__column-content--marginal">  <div id="bJS_article"> <div class="b_textmedia__imagewrap b_textmedia__imagewrap--right b_textmedia__imagewrap--half "><figure class="b_textmedia__figure"><picture><source srcset="/fileadmin/_processed_/6/4/csm_1224-900-Sponsored-Ashei-Kasei-In-Article2_249b5c98de.webp" media="(min-width: 1280px)" type="image/webp" /><source srcset="/fileadmin/_processed_/6/4/csm_1224-900-Sponsored-Ashei-Kasei-In-Article2_9cf9166448.png" media="(min-width: 1280px)" /><source srcset="/fileadmin/_processed_/6/4/csm_1224-900-Sponsored-Ashei-Kasei-In-Article2_30cee7ebff.webp" media="(min-width: 1024px)" type="image/webp" /><source srcset="/fileadmin/_processed_/6/4/csm_1224-900-Sponsored-Ashei-Kasei-In-Article2_1b63a97878.png" media="(min-width: 1024px)" /><source srcset="/fileadmin/_processed_/6/4/csm_1224-900-Sponsored-Ashei-Kasei-In-Article2_df59570e06.webp" media="(min-width: 835px)" type="image/webp" /><source srcset="/fileadmin/_processed_/6/4/csm_1224-900-Sponsored-Ashei-Kasei-In-Article2_6527de7777.png" media="(min-width: 835px)" /><source srcset="/fileadmin/_processed_/6/4/csm_1224-900-Sponsored-Ashei-Kasei-In-Article2_f0743fc0dd.webp" media="(min-width: 768px)" type="image/webp" /><source srcset="/fileadmin/_processed_/6/4/csm_1224-900-Sponsored-Ashei-Kasei-In-Article2_080859f6da.png" media="(min-width: 768px)" /><source srcset="/fileadmin/_processed_/6/4/csm_1224-900-Sponsored-Ashei-Kasei-In-Article2_81b714c9b8.webp" media="(min-width: 567px)" type="image/webp" /><source srcset="/fileadmin/_processed_/6/4/csm_1224-900-Sponsored-Ashei-Kasei-In-Article2_33ca6befb9.png" media="(min-width: 567px)" /><source srcset="/fileadmin/_processed_/6/4/csm_1224-900-Sponsored-Ashei-Kasei-In-Article2_eae33e9964.webp" media="(min-width: 415px)" type="image/webp" /><source srcset="/fileadmin/_processed_/6/4/csm_1224-900-Sponsored-Ashei-Kasei-In-Article2_00378e59da.png" media="(min-width: 415px)" /><source srcset="/fileadmin/_processed_/6/4/csm_1224-900-Sponsored-Ashei-Kasei-In-Article2_cb38247381.webp" type="image/webp" /><img class="b_textmedia__image" src="/fileadmin/_processed_/6/4/csm_1224-900-Sponsored-Ashei-Kasei-In-Article2_edd74b54b2.png" width="374" height="214" loading="lazy" alt="" /></picture><figcaption class="b_textmedia__figcaption"><p class="b_rte__bodytext">Brian Crawford</p></figcaption></figure><figure class="b_textmedia__figure"><picture><source srcset="/fileadmin/_processed_/a/f/csm_1224-900-Sponsored-Ashei-Kasei-In-Article3_d4b2ef6839.webp" media="(min-width: 1280px)" type="image/webp" /><source srcset="/fileadmin/_processed_/a/f/csm_1224-900-Sponsored-Ashei-Kasei-In-Article3_a2d2171c20.png" media="(min-width: 1280px)" /><source srcset="/fileadmin/_processed_/a/f/csm_1224-900-Sponsored-Ashei-Kasei-In-Article3_7c4dcd25c7.webp" media="(min-width: 1024px)" type="image/webp" /><source srcset="/fileadmin/_processed_/a/f/csm_1224-900-Sponsored-Ashei-Kasei-In-Article3_823e367e35.png" media="(min-width: 1024px)" /><source srcset="/fileadmin/_processed_/a/f/csm_1224-900-Sponsored-Ashei-Kasei-In-Article3_3a90ef0d27.webp" media="(min-width: 835px)" type="image/webp" /><source srcset="/fileadmin/_processed_/a/f/csm_1224-900-Sponsored-Ashei-Kasei-In-Article3_3170ceae8a.png" media="(min-width: 835px)" /><source srcset="/fileadmin/_processed_/a/f/csm_1224-900-Sponsored-Ashei-Kasei-In-Article3_1af2da1f1b.webp" media="(min-width: 768px)" type="image/webp" /><source srcset="/fileadmin/_processed_/a/f/csm_1224-900-Sponsored-Ashei-Kasei-In-Article3_30ebc8be82.png" media="(min-width: 768px)" /><source srcset="/fileadmin/_processed_/a/f/csm_1224-900-Sponsored-Ashei-Kasei-In-Article3_d89032a1ff.webp" media="(min-width: 567px)" type="image/webp" /><source srcset="/fileadmin/_processed_/a/f/csm_1224-900-Sponsored-Ashei-Kasei-In-Article3_bd52d8902c.png" media="(min-width: 567px)" /><source srcset="/fileadmin/_processed_/a/f/csm_1224-900-Sponsored-Ashei-Kasei-In-Article3_0e66368b99.webp" media="(min-width: 415px)" type="image/webp" /><source srcset="/fileadmin/_processed_/a/f/csm_1224-900-Sponsored-Ashei-Kasei-In-Article3_30aa826af8.png" media="(min-width: 415px)" /><source srcset="/fileadmin/_processed_/a/f/csm_1224-900-Sponsored-Ashei-Kasei-In-Article3_d8c31c71a6.webp" type="image/webp" /><img class="b_textmedia__image" src="/fileadmin/_processed_/a/f/csm_1224-900-Sponsored-Ashei-Kasei-In-Article3_44098423df.png" width="374" height="214" loading="lazy" alt="" /></picture><figcaption class="b_textmedia__figcaption"><p class="b_rte__bodytext">Doug Chritton</p></figcaption></figure></div><p class="b_rte__bodytext">Historically, oligonucleotide therapies have targeted small patient populations with rare conditions, but with excitement growing in tandem with the potential of the treatments themselves, innovators are looking to target indications with larger numbers of patients.<br><br>When one particular company was looking to optimize a manufacturing space for oligonucleotide manufacturing, Asahi Kasei Bioprocess (AKB) and CRB were invited to offer expertise in terms of the floor design and process equipment. The focus of the project: improving quality, purity, and output, while minimizing environmental impact. Here, AKB Vice President of Operations Brian Crawford and CRB Process Engineer Doug Chritton tell us more.</p><h4 class="b_rte__header b_rte__header--h4">What are the big trends in oligonucleotide manufacture?<br> </h4><p class="b_rte__bodytext"><strong>Doug Chritton:</strong> CMOs are building out capacity to support these drugs and capacities are also being boosted on the clinical side with an eye to even larger throughput in the future. There’s also interest in advancing production techniques. The traditional way of building a molecule – one nucleotide at a time on solid phase supports – is no longer the best approach; it uses a lot of solvents, isn’t sustainable, and isn’t designed to produce quantities to suit the demands of a large patient population.<br><br>We’re now seeing a push for enzymatic synthesis to link molecules and reduce the number of harmful chemicals and flammable liquids, while also increasing yield.<br><br>For example, if a 20 nucleotide long oligo product (20-mer) is 98 percent effective at every linkage, you have around a 67 percent yield, which isn’t great but is acceptable for drugs targeting small patient populations. As we look at longer chains and larger populations, however, that yield becomes less feasible. A 100-mer, for an application such as a guide RNA for CRISPR therapies, may only have around a 13 percent yield. These longer chain molecules aren’t necessarily targeting large patient populations, but would still benefit from enzymatic production methods and improved yields. There is also room to improve other manufacturing steps. Advanced drying techniques, such as spray drying, are seeing increased attention, as are enhanced purification methods.<br><br>The industry is recognizing that the status quo is not a sustainable production approach if we need large quantities of oligonucleotide therapies in the future.</p><div class="b_clearfix"></div> <div class="b_textmedia__imagewrap b_textmedia__imagewrap--above b_textmedia__imagewrap--full "><figure class="b_textmedia__figure"><picture><source srcset="/fileadmin/_processed_/0/e/csm_1224-900-Sponsored-Ashei-Kasei-Teaser_86c7ff0174.webp" media="(min-width: 1280px)" type="image/webp" /><source srcset="/fileadmin/_processed_/0/e/csm_1224-900-Sponsored-Ashei-Kasei-Teaser_8ab9ee64d1.png" media="(min-width: 1280px)" /><source srcset="/fileadmin/_processed_/0/e/csm_1224-900-Sponsored-Ashei-Kasei-Teaser_5b09262d19.webp" media="(min-width: 1024px)" type="image/webp" /><source srcset="/fileadmin/_processed_/0/e/csm_1224-900-Sponsored-Ashei-Kasei-Teaser_9f63261f76.png" media="(min-width: 1024px)" /><source srcset="/fileadmin/_processed_/0/e/csm_1224-900-Sponsored-Ashei-Kasei-Teaser_d9913d381d.webp" media="(min-width: 835px)" type="image/webp" /><source srcset="/fileadmin/_processed_/0/e/csm_1224-900-Sponsored-Ashei-Kasei-Teaser_198a0227cd.png" media="(min-width: 835px)" /><source srcset="/fileadmin/_processed_/0/e/csm_1224-900-Sponsored-Ashei-Kasei-Teaser_06af6e0b3f.webp" media="(min-width: 768px)" type="image/webp" /><source srcset="/fileadmin/_processed_/0/e/csm_1224-900-Sponsored-Ashei-Kasei-Teaser_7bb293bc62.png" media="(min-width: 768px)" /><source srcset="/fileadmin/_processed_/0/e/csm_1224-900-Sponsored-Ashei-Kasei-Teaser_247f8695f3.webp" media="(min-width: 567px)" type="image/webp" /><source srcset="/fileadmin/_processed_/0/e/csm_1224-900-Sponsored-Ashei-Kasei-Teaser_8777167e38.png" media="(min-width: 567px)" /><source srcset="/fileadmin/_processed_/0/e/csm_1224-900-Sponsored-Ashei-Kasei-Teaser_42f3a7653f.webp" media="(min-width: 415px)" type="image/webp" /><source srcset="/fileadmin/_processed_/0/e/csm_1224-900-Sponsored-Ashei-Kasei-Teaser_683ccce4bb.png" media="(min-width: 415px)" /><source srcset="/fileadmin/_processed_/0/e/csm_1224-900-Sponsored-Ashei-Kasei-Teaser_d5418fc62b.webp" type="image/webp" /><img class="b_textmedia__image" src="/fileadmin/_processed_/0/e/csm_1224-900-Sponsored-Ashei-Kasei-Teaser_c190839ff1.png" width="374" height="250" loading="lazy" alt="" /></picture></figure></div><h4 class="b_rte__header b_rte__header--h4">What are the main challenges in optimizing a manufacturing space for oligonucleotides?<br> </h4><p class="b_rte__bodytext"><strong>Brian Crawford: </strong>The oligonucleotides field is booming, but there is a dearth of experienced personnel for this emerging modality. And it is always a challenge to outfit a facility for current state-of-the-art manufacturing methods, while also considering and building flexibility for future manufacturing advances. It is important to keep advanced methods in mind. Whether enzymatic processes, liquid phase synthesis, building the sequences with nucleotide triphosphates rather than phosphoramidites, there are all kinds of advanced manufacturing techniques that could be employed to solve the current challenges being seen in oligo manufacturing.<br><br>You are also best finding a partner who is familiar with the challenges. There are many aspects to consider – and many timelines must converge – to get a new manufacturing space qualified and ready to go. You must consider local government permits, inspections timing, associated utility supply and piping, HVAC, qualification, construction of warehouse space and storage, supporting labs for product testing and clearance, and more. Simply ensuring that essential equipment can fit into elevators, through halls and corridors, and into the appropriate room is often overlooked!<br><br>Collaborating with an experienced partner brings familiarity and expertise in navigating all challenges. Scale up is not always about making everything bigger. The emphasis should be on increasing throughput, yield, and purity, which can increase the amount of product manufactured without requiring infinitely scalable machines.</p><h4 class="b_rte__header b_rte__header--h4">How does the complementary expertise of both companies come together in the project in question?<br> </h4><p class="b_rte__bodytext"><strong>DC:</strong> CRB was initially asked to perform a small gap analysis for a client involving an oligonucleotide project, including a review of the facility and potential improvements, and then was hired to design support systems, such as solvent supply, reagent supply, buffer preparation, and waste handling systems. AKB was tasked with providing a large portion of the process equipment. Both companies worked closely together to ensure the equipment fit the facility and supported the needs of the client.<br><br>Even before this project, we already had a collaborative relationship where we would often share trends and help each other understand what clients need and want.<br><br><strong>BC:</strong> AKB and CRB are aligned in solving shared customers’ manufacturing challenges in a way that drives the industry forward. On this project, we were selected as the equipment supplier for three of the manufacturing lines. Our history with CRB was advantageous because they already had experience with our equipment, understanding how we can tie it into the plant-wide controls and ancillaries that feed manufacturing processes.</p><div class="b_clearfix"></div> <div class="b_textmedia__imagewrap b_textmedia__imagewrap--above b_textmedia__imagewrap--full "><figure class="b_textmedia__figure"><picture><source srcset="/fileadmin/_processed_/6/c/csm_1224-900-Sponsored-Ashei-Kasei-InArticle_3b633ad44c.webp" media="(min-width: 1280px)" type="image/webp" /><source srcset="/fileadmin/_processed_/6/c/csm_1224-900-Sponsored-Ashei-Kasei-InArticle_fdde5aa8fb.png" media="(min-width: 1280px)" /><source srcset="/fileadmin/_processed_/6/c/csm_1224-900-Sponsored-Ashei-Kasei-InArticle_aea899d858.webp" media="(min-width: 1024px)" type="image/webp" /><source srcset="/fileadmin/_processed_/6/c/csm_1224-900-Sponsored-Ashei-Kasei-InArticle_87b53d3a20.png" media="(min-width: 1024px)" /><source srcset="/fileadmin/_processed_/6/c/csm_1224-900-Sponsored-Ashei-Kasei-InArticle_6defee67c9.webp" media="(min-width: 835px)" type="image/webp" /><source srcset="/fileadmin/_processed_/6/c/csm_1224-900-Sponsored-Ashei-Kasei-InArticle_2372dbf51c.png" media="(min-width: 835px)" /><source srcset="/fileadmin/_processed_/6/c/csm_1224-900-Sponsored-Ashei-Kasei-InArticle_fa81786478.webp" media="(min-width: 768px)" type="image/webp" /><source srcset="/fileadmin/_processed_/6/c/csm_1224-900-Sponsored-Ashei-Kasei-InArticle_520788c18f.png" media="(min-width: 768px)" /><source srcset="/fileadmin/_processed_/6/c/csm_1224-900-Sponsored-Ashei-Kasei-InArticle_84ca8e09f9.webp" media="(min-width: 567px)" type="image/webp" /><source srcset="/fileadmin/_processed_/6/c/csm_1224-900-Sponsored-Ashei-Kasei-InArticle_61f3eec786.png" media="(min-width: 567px)" /><source srcset="/fileadmin/_processed_/6/c/csm_1224-900-Sponsored-Ashei-Kasei-InArticle_804c827d09.webp" media="(min-width: 415px)" type="image/webp" /><source srcset="/fileadmin/_processed_/6/c/csm_1224-900-Sponsored-Ashei-Kasei-InArticle_349b76b26a.png" media="(min-width: 415px)" /><source srcset="/fileadmin/_processed_/6/c/csm_1224-900-Sponsored-Ashei-Kasei-InArticle_95208a2870.webp" type="image/webp" /><img class="b_textmedia__image" src="/fileadmin/_processed_/6/c/csm_1224-900-Sponsored-Ashei-Kasei-InArticle_e7c118b97d.png" width="374" height="181" loading="lazy" alt="" /></picture></figure></div><h4 class="b_rte__header b_rte__header--h4">What were some of the big discussion points in the project?<br> </h4><p class="b_rte__bodytext"><strong>BC:</strong> There were discussions around how the customer wanted to approach the plant-wide controls for data management, including considerations for the future, such as further automation, industry 4.0 initiatives, and space planning. Indeed, a great deal of space planning went into the design of our oligosynthesizer, our UF/DF systems, and chromatography purification systems to make sure that they fit into the vision for the customer.<br><br><strong>DC:</strong> In oligo facilities, handling corrosive halogenated waste is a huge discussion point. If you put the deblock or detritylation reagent undiluted into a stainless-steel piping system, then you’ll have issues with corrosion. It’s a very hazardous safety and environmental issue. Halogenated waste is a small portion in comparison, so evaluating the trade off is something that needs to be weighed carefully.</p><h4 class="b_rte__header b_rte__header--h4">What will define the success of this project?<br> </h4><p class="b_rte__bodytext"><strong>BC:</strong> Thus far, the project has been a success in that we’ve been able to handle shifting priorities and keep everything on-track or ahead of schedule. The real success will be defined by the customer when their first batches of clinical and process-scale oligonucleotides are complete. From an equipment standpoint, we know we’re on track as two full pilot scale trains are installed and qualified. The process scale train is currently in validation testing and everyone is very happy so far! We do recognize, however, that this is just the start. We’re now shifting focus to operator training and setting them up for success prior to production. The aim is to contribute as much as we can by ensuring the equipment is set up optimally and ready to run.</p><div class="b_clearfix"></div> <section class="b_content-adbox"> <span class="b_content-adbox__tag">NEWS</span> <div class="b_content-adbox__box"> <p class="b_content-adbox__kicker">The Medicine Maker Presents:</p> <header class="b_content-adbox__header">The Medicine Maker Newsletter</header> <p class="b_content-adbox__text">Enjoying yourself? There's plenty more where that came from! Our weekly Newsletter brings you the most popular stories as they unfold, chosen by our fantastic Editorial team!</p> <p class="b_content-adbox__linktext"> <a href="http://tmm.txp.to/ad/newsletter/01" target="_blank" rel="noreferrer" class="b_content-adbox__link">Register for our weekly newsletter</a> </p> </div> </section> <h4 class="b_rte__header b_rte__header--h4">What are your top tips for optimizing an oligonucleotide manufacturing space?<br> </h4><p class="b_rte__bodytext"><strong>DC: </strong>For contract manufacturers, flexibility is key. Don’t design your facility by honing in on existing processes; 5–10 years down the road, you will need to either add, change, or modify your equipment and facility. Think about how you can accommodate that by planning, planning, and planning some more! Consider not just the process, but the entire operation.<br><br><strong>BC: </strong>I agree. Knowing what the ideal use case is and planning for change over time is important. Keeping operations in sequence, thinking about critical interfaces between the building, the operator, and the ancillary support systems are also key focal points. At AKB, we focus on developing systems for these challenges that also save down-time, floor space, and drive up the production capacity for customers.</p><h4 class="b_rte__header b_rte__header--h4">What are your thoughts on the future of oligo drug development?<br> </h4><p class="b_rte__bodytext"><strong>BC:</strong> I’m excited because of what these treatments represent. Rather than palliative or symptomatic treatments, oligos can be curative – whether through gene silencing or RNA interference. There are many developments targeting rare diseases that have no treatment, but it’s also exciting to think about using oligos in diseases with potentially hundreds of millions of patients.<br><br>We’re also seeing more breakthroughs in effective delivery to tissues and we will see more approvals in the future. The status quo will be pushed to one side; the state-of-theart will be pushed further. It’s exciting, on a professional level, to be able to contribute and help drive the field forward.<br><br>When it comes to manufacturing, I don’t think there will be a single, golden manufacturing approach. It will likely be hybrid – or possibly something new that hasn’t been considered yet. But whatever the approach, it seems clear that there will be an emphasis on larger scales, greater efficiency, and improved sustainability.<br><br><strong>DC:</strong> Oligonucleotides with conjugates is really exciting. New targeting ligands are starting to unlock parts that have been difficult to treat; access to these targets will create new treatment options. By conjugating to an oligonucleotide, we can harness a long duration of action or potential curative action to treat diseases with unmet needs. As we find more conjugates, the oligo targets will diversify to other organs too, resulting in even faster growth of the market segment.<br><br>If we draw comparisons to monoclonal antibodies, there were just a handful of approved therapies 25 years ago. Today, there are over 120. We’re on the edge of that with oligonucleotide treatments.<br><br>Find out more at <a href="https://fluidmgmt.ak-bio.com/" target="_blank" rel="noreferrer">https://fluidmgmt.ak-bio.com/</a></p><div class="b_clearfix"></div> </div>  <div class="b_access__grid"> <div class="b_access__column"> <header class="b_loginregister__header b_loginregister__header--h3"> Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors. </header> <div id="quick-registration"></div> <div class="b_main__column b_main__column--center"> <div class="b_message__quick-registration"> </div> <form method="post" name="registration" class="b_form" action="/manufacture/the-status-quo-of-oligonucleotides-is-not-the-future?tx_txp_quickregistration%5Baction%5D=create&tx_txp_quickregistration%5Bcontroller%5D=QuickRegistration&cHash=e5b90e6c478ece6ff89443b9cd72ee9e#quick-registration"> <div> <input type="hidden" name="tx_txp_quickregistration[__referrer][@extension]" value="Txp" /> <input type="hidden" name="tx_txp_quickregistration[__referrer][@controller]" value="QuickRegistration" /> <input type="hidden" name="tx_txp_quickregistration[__referrer][@action]" value="show" /> <input type="hidden" name="tx_txp_quickregistration[__referrer][arguments]" value="YTowOnt90fe826eba926d8c6af15972884645d2740b4e91a" /> <input type="hidden" name="tx_txp_quickregistration[__referrer][@request]" value="{"@extension":"Txp","@controller":"QuickRegistration","@action":"show"}961af8bf435eb9a8f676a171214c28cf91999fcb" /> <input type="hidden" name="tx_txp_quickregistration[__trustedProperties]" value="{"registration":{"email":1,"password":1,"termsOfUse":1,"newsletterTopicTsmm":1,"newsletterCellGene":1,"newsletterBioprocess":1}}bc246658cbba7e671db536d9fb4bf75270b95a19" /> </div> <fieldset class="b_form__fieldset"> <div class="b_form__grid"> <div class="b_form__fieldgroup b_form__fieldgroup--half"> <label for="email" class="b_form__label">Email*</label> <input class="b_form__textinput" id="email" type="email" name="tx_txp_quickregistration[registration][email]" value="" /> </div> <div class="b_form__fieldgroup b_form__fieldgroup--half"> <label for="password" class="b_form__label">Choose a password*</label> <input class="b_form__textinput" id="password" type="password" name="tx_txp_quickregistration[registration][password]" value="" /> </div> </div> </fieldset> <fieldset class="b_form__fieldset"> <div class="b_form__grid"> <div class="b_form__fieldgroup"> <input type="hidden" name="tx_txp_quickregistration[registration][termsOfUse]" value="" /><input class="b_form__checkbox" id="termsofuse" type="checkbox" name="tx_txp_quickregistration[registration][termsOfUse]" value="1" /> <label for="termsofuse" class="b_form__label b_form__label--checkbox"><span data-click="termsofuse">I have read and understand the </span> <a class="b_form__link" target="_blank" href="/privacy-notice">Privacy Notice</a> * </label> </div> </div> <strong> Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in </strong> <div class="b_form__grid"> <div class="b_form__fieldgroup"> <input type="hidden" name="tx_txp_quickregistration[registration][newsletterTopicTsmm]" value="" /><input class="b_form__checkbox" id="newsletterTopicTsmm" type="checkbox" name="tx_txp_quickregistration[registration][newsletterTopicTsmm]" value="1" /> <label for="newsletterTopicTsmm" class="b_form__label b_form__label--checkbox"> I want to stay up to date with the "Small Molecule" field </label> <input type="hidden" name="tx_txp_quickregistration[registration][newsletterCellGene]" value="" /><input class="b_form__checkbox" id="newsletterCellGene" type="checkbox" name="tx_txp_quickregistration[registration][newsletterCellGene]" value="1" /> <label for="newsletterCellGene" class="b_form__label b_form__label--checkbox"> I want to stay up to date with the Cell and Gene field </label> <input type="hidden" name="tx_txp_quickregistration[registration][newsletterBioprocess]" value="" /><input class="b_form__checkbox" id="newsletterBioprocess" type="checkbox" name="tx_txp_quickregistration[registration][newsletterBioprocess]" value="1" /> <label for="newsletterBioprocess" class="b_form__label b_form__label--checkbox"> I want to stay up to date with the Bioprocessing field </label> </div> </div> <p class="b_form__text"> When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at <a href="/cdn-cgi/l/email-protection#a1c8cfc7cee1d5c9c4ccc4c5c8c2c8cfc4ccc0cac4d38fc2cecc" class="b_form__link"><span class="__cf_email__" data-cfemail="d9b0b7bfb699adb1bcb4bcbdb0bab0b7bcb4b8b2bcabf7bab6b4">[email protected]</span></a>. <br /><small>If you wish to unsubscribe, you can update your preferences at any point.</small> </p> </fieldset> <fieldset class="b_form__fieldset"> <div class="b_form__grid"> <div class="b_form__fieldgroup "> <input class="b_button bJS_tracking_registration-2" type="submit" value="Subscribe" /> </div> </div> </fieldset> </form> </div> </div> </div> <div class="b_article__footer"> <ul class="b_menu-share b_menu-share--bottom"> <li class="b_menu-share__item"> <vue-bookmark :uid="12047" :user="user" :is-share="true"></vue-bookmark> </li> <li class="b_menu-share__item"> <a href="/cdn-cgi/l/email-protection#300f4345525a5553440d645859431502005d59575844150200595e445542554344150200495f4516525f54490d58444440431503711502761502764458555d55545953595e555d515b55421e535f5d1502765d515e45565153444542551502764458551d4344514445431d41455f1d5f561d5f5c59575f5e45535c555f44595455431d59431d5e5f441d4458551d564544454255" class="b_menu-share__link b_menu-share__link--email" target="_blank" rel="noopener" title="Share this article by email"></a> </li> <li class="b_menu-share__item"> <a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fthemedicinemaker.com%2Fmanufacture%2Fthe-status-quo-of-oligonucleotides-is-not-the-future" class="b_menu-share__link b_menu-share__link--facebook" target="_blank" rel="noopener" title="Share this article on Facebook"></a> </li> <li class="b_menu-share__item"> <a href="https://www.linkedin.com/shareArticle?url=https%3A%2F%2Fthemedicinemaker.com%2Fmanufacture%2Fthe-status-quo-of-oligonucleotides-is-not-the-future" class="b_menu-share__link b_menu-share__link--linkedin" target="_blank" rel="noopener" title="Share this article on LinkedIn"></a> </li> <li class="b_menu-share__item"> <a class="b_menu-share__link b_menu-share__link--twitter-x" href="https://x.com/share?url=https%3A%2F%2Fthemedicinemaker.com%2Fmanufacture%2Fthe-status-quo-of-oligonucleotides-is-not-the-future" target="_blank" rel="noopener" title="Share this article on X"></a> </li> <li class="b_menu-share__item"> <a class="b_menu-share__link b_menu-share__link--doximity" href="https://www.doximity.com/conversations/new?url=https%3A%2F%2Fthemedicinemaker.com%2Fmanufacture%2Fthe-status-quo-of-oligonucleotides-is-not-the-future" target="_blank" rel="noopener" title="Share this article on Doximity"></a> </a> </li> <li class="b_menu-share__item"> <a href="javascript:window.print()" class="b_menu-share__link b_menu-share__link--print" title="Print this article"></a> </li> </ul> <span class="b_category__container "> <a href="/manufacture" class="b_category b_category--color-2 b_category--title b_category--has-topic "> Manufacture </a> <a class="b_category b_category--color-2 b_category--topic " href="/manufacture/advanced-medicine"> Advanced Medicine </a> </span> </div> </div> <div class="b_main__column-marginal"> <div class="b_teaser__grid"> <section class="b_teaser__column b_teaser__column--marginal"> <header class="b_teaser__header b_teaser__header--h3">Related White Papers</header> <div class="b_teaser b_teaser--article"> <vue-bookmark :uid="11870" :category="0" :user="user" :position-right="true"></vue-bookmark> <header class="b_teaser__headline b_teaser__headline--h3 b_teaser__headline--marginal"> <a href="/white-papers/single-ingredient-optimization-supports-the-expansion-of-pluripotent-stem-cells" class="b_teaser__link">Single ingredient optimization supports the expansion of pluripotent stem cells</a> </header> <p class="b_teaser__info b_teaser__info--article "> <time datetime="2024-09-04" >09/04/2024</time> | Contributed by Novo Nordisk </p> </div> <div class="b_teaser b_teaser--article"> <vue-bookmark :uid="8960" :category="0" :user="user" :position-right="true"></vue-bookmark> <header class="b_teaser__headline b_teaser__headline--h3 b_teaser__headline--marginal"> <a href="/white-papers/how-to-improve-the-capturing-of-antibody-fragments" class="b_teaser__link">How to Improve the Capturing of Antibody Fragments</a> </header> <p class="b_teaser__info b_teaser__info--article "> <time datetime="2021-04-06" >04/06/2021</time> | Contributed by Tosoh </p> </div> <div class="b_teaser b_teaser--article"> <vue-bookmark :uid="8813" :category="0" :user="user" :position-right="true"></vue-bookmark> <header class="b_teaser__headline b_teaser__headline--h3 b_teaser__headline--marginal"> <a href="/white-papers/accelerate-innovation-and-manufacturing-to-better-serve-patients" class="b_teaser__link">Accelerate innovation and manufacturing to better serve patients</a> </header> <p class="b_teaser__info b_teaser__info--article "> <time datetime="2021-02-23" >02/23/2021</time> | Contributed by GenScript Probio </p> </div> </section> </div> <div class="b_teaser__grid"> <section class="b_teaser__column b_teaser__column--marginal"> <header class="b_teaser__header b_teaser__header--h3">Related Webinars</header> <div class="b_teaser b_teaser--article"> <vue-bookmark :uid="11855" :category="2" :user="user" :position-right="true"></vue-bookmark> <span class="b_category__container "> <a href="/manufacture" class="b_category b_category--color-2 b_category--has-topic b_category--narrow"> Manufacture </a> <a class="b_category b_category--color-2 b_category--topic b_category--narrow" href="/manufacture/bioprocessing-single-use-systems"> Bioprocessing - Single Use Systems </a> </span> <header class="b_teaser__headline b_teaser__headline--h3 b_teaser__headline--marginal"> <a href="/webinar/empowering-you-to-master-control-predictability-and-efficiency-partnering-in-your-digital-transformation" class="b_teaser__link">Empowering you to master control, predictability, and efficiency, partnering in your digital transformation</a> </header> <p class="b_teaser__info b_teaser__info--article "> <time datetime="2024-12-09" >12/09/2024</time> | Sponsored by Merck </p> </div> <div class="b_teaser b_teaser--article"> <vue-bookmark :uid="11977" :category="2" :user="user" :position-right="true"></vue-bookmark> <span class="b_category__container "> <a href="/manufacture" class="b_category b_category--color-2 b_category--has-topic b_category--narrow"> Manufacture </a> <a class="b_category b_category--color-2 b_category--topic b_category--narrow" href="/manufacture/bioprocessing-upstream-downstream"> Bioprocessing - Upstream & Downstream </a> </span> <header class="b_teaser__headline b_teaser__headline--h3 b_teaser__headline--marginal"> <a href="/webinar/intensification-not-complication" class="b_teaser__link">Intensification, not complication</a> </header> <p class="b_teaser__info b_teaser__info--article "> <time datetime="2024-11-05" >11/05/2024</time> | Sponsored by Cytiva </p> </div> <div class="b_teaser b_teaser--article"> <vue-bookmark :uid="11747" :category="2" :user="user" :position-right="true"></vue-bookmark> <span class="b_category__container "> <a href="/manufacture" class="b_category b_category--color-2 b_category--has-topic b_category--narrow"> Manufacture </a> <a class="b_category b_category--color-2 b_category--topic b_category--narrow" href="/manufacture/process-control"> Process Control </a> </span> <header class="b_teaser__headline b_teaser__headline--h3 b_teaser__headline--marginal"> <a href="/webinar/raman-spectroscopy-and-process-analytical-technology-improving-spps-in-pharmaceutical-manufacturing" class="b_teaser__link">Raman Spectroscopy and Process Analytical Technology: Improving SPPS in Pharmaceutical Manufacturing</a> </header> <p class="b_teaser__info b_teaser__info--article "> <time datetime="2024-10-30" >10/30/2024</time> | Sponsored by Corden Pharma </p> </div> </section> </div> <div class="b_teaser__grid"> <section class="b_teaser__column b_teaser__column--marginal"> <header class="b_teaser__header b_teaser__header--h3">Most Popular</header> <div class="b_teaser b_teaser--popular b_teaser--popular-marginal"> <span class="b_teaser__count b_teaser__count--marginal">1.</span> <vue-bookmark :uid="12173" :category="2" :user="user" :position-right="true"></vue-bookmark> <span class="b_category__container "> <a href="/manufacture" class="b_category b_category--color-2 b_category--has-topic b_category--narrow"> Manufacture </a> <a class="b_category b_category--color-2 b_category--topic b_category--narrow" href="/manufacture/bioprocessing-upstream-downstream"> Bioprocessing - Upstream & Downstream </a> </span> <header class="b_teaser__headline b_teaser__headline--h3 b_teaser__headline--marginal"> <a href="/manufacture/mastering-oligonucleotide-manufacturing" class="b_teaser__link">Mastering Oligonucleotide Manufacturing</a> </header> <p class="b_teaser__info b_teaser__info--article "> <time datetime="2025-01-16" >01/16/2025</time> </p> </div> <div class="b_teaser b_teaser--popular b_teaser--popular-marginal"> <span class="b_teaser__count b_teaser__count--marginal">2.</span> <vue-bookmark :uid="12221" :category="3" :user="user" :position-right="true"></vue-bookmark> <span class="b_category__container "> <a href="/business-regulation" class="b_category b_category--color-3 b_category--has-topic b_category--narrow"> Business & Regulation </a> <a class="b_category b_category--color-3 b_category--topic b_category--narrow" href="/business-regulation/profession"> Profession </a> </span> <header class="b_teaser__headline b_teaser__headline--h3 b_teaser__headline--marginal"> <a href="/discovery-development/maintaining-momentum" class="b_teaser__link">Maintaining Momentum</a> </header> <p class="b_teaser__info b_teaser__info--article "> <time datetime="2025-02-06" >02/06/2025</time> | 4 min read </p> </div> <div class="b_teaser b_teaser--popular b_teaser--popular-marginal"> <span class="b_teaser__count b_teaser__count--marginal">3.</span> <vue-bookmark :uid="12216" :category="2" :user="user" :position-right="true"></vue-bookmark> <span class="b_category__container "> <a href="/manufacture" class="b_category b_category--color-2 b_category--has-topic b_category--narrow"> Manufacture </a> <a class="b_category b_category--color-2 b_category--topic b_category--narrow" href="/manufacture/advanced-medicine"> Advanced Medicine </a> </span> <header class="b_teaser__headline b_teaser__headline--h3 b_teaser__headline--marginal"> <a href="/manufacture/digital-twins-in-car-t-manufacturing" class="b_teaser__link">Digital Twins in CAR-T Manufacturing</a> </header> <p class="b_teaser__info b_teaser__info--article "> <time datetime="2025-02-04" >02/04/2025</time> | Marc-Olivier Baradez | 4 min read </p> </div> <div class="b_teaser b_teaser--popular b_teaser--popular-marginal"> <span class="b_teaser__count b_teaser__count--marginal">4.</span> <vue-bookmark :uid="12227" :category="2" :user="user" :position-right="true"></vue-bookmark> <span class="b_category__container "> <a href="/manufacture" class="b_category b_category--color-2 b_category--has-topic b_category--narrow"> Manufacture </a> <a class="b_category b_category--color-2 b_category--topic b_category--narrow" href="/manufacture/small-molecules"> Small Molecules </a> </span> <header class="b_teaser__headline b_teaser__headline--h3 b_teaser__headline--marginal"> <a href="/manufacture/2025-predictions-for-rna-therapeutics" class="b_teaser__link">2025 Predictions for RNA Therapeutics</a> </header> <p class="b_teaser__info b_teaser__info--article "> <time datetime="2025-02-10" >02/10/2025</time> | Kate Broderick | 5 min read </p> </div> <div class="b_teaser b_teaser--popular b_teaser--popular-marginal"> <span class="b_teaser__count b_teaser__count--marginal">5.</span> <vue-bookmark :uid="12205" :category="2" :user="user" :position-right="true"></vue-bookmark> <span class="b_category__container "> <a href="/manufacture" class="b_category b_category--color-2 b_category--has-topic b_category--narrow"> Manufacture </a> <a class="b_category b_category--color-2 b_category--topic b_category--narrow" href="/manufacture/vaccines"> Vaccines </a> </span> <header class="b_teaser__headline b_teaser__headline--h3 b_teaser__headline--marginal"> <a href="/manufacture/understanding-the-h5n1-threat" class="b_teaser__link">Understanding the H5N1 Threat</a> </header> <p class="b_teaser__info b_teaser__info--article "> <time datetime="2025-02-03" >02/03/2025</time> | Stephanie Vine | 4 min read </p> </div> </section> </div> </div> </div> </div> <vue-reading-list-tracking :page-uid="12047" :user="user" ></vue-reading-list-tracking> <vue-modal></vue-modal> </main> <div id="bJS_additional" class="b_additional"> <div class="b_additional__container"> <div class="b_additional__grid"> <div class="b_additional__column"> <div class="b_additional__innerwrap"> <header class="b_additional__headline b_additional__headline--h2"> Register to The Medicine Maker </header> <p class="b_rte__bodytext">Register to access our FREE online portfolio, request the magazine in print and manage your preferences.</p> <header class="b_page__header b_page__header--h4">You will benefit from:</header> <ul class="b_rte__list b_rte__list--check"> <li class="b_rte__listitem">Unlimited access to ALL articles</li> <li class="b_rte__listitem">News, interviews & opinions from leading industry experts</li> <li class="b_rte__listitem">Receive print (and PDF) copies of The Medicine Maker magazine</li> </ul> <p class="b_rte__bodytext"> <a class="b_button bJS_tracking_registration-1" href="/login/sign-up">Register</a> </p> </div> </div> <div class="b_additional__column"> <div class="b_additional__innerwrap"> <div class="b_issuelist"> <header class="b_issuelist__header b_issuelist__header--h2"> December Issue of The Medicine Maker </header> <picture><source srcset="/fileadmin/_processed_/d/6/csm_1224_TMM_Nov_Dec_0fcd4ffa86.webp" type="image/webp" /><img class="b_issuelist__image" src="/fileadmin/_processed_/d/6/csm_1224_TMM_Nov_Dec_bbefc2e903.png" width="180" height="229" loading="lazy" alt="" /></picture> <ul class="b_issuelist__list "> <li class="b_issuelist__item "> <span class="b_category__container "> <a href="/business-regulation" class="b_category b_category--color-3 "> Business & Regulation </a> </span> <p class="b_issuelist__headline b_issuelist__headline--h3"> <a href="/business-regulation/sustainability-modern-supply-chains-and-the-pharma-industry" class="b_issuelist__link">The Intersection of Sustainability</a> </p> </li> <li class="b_issuelist__item "> <span class="b_category__container "> <a href="/discovery-development" class="b_category b_category--color-1 "> Discovery & Development </a> </span> <p class="b_issuelist__headline b_issuelist__headline--h3"> <a href="/discovery-development/boosting-vaccine-stability-with-gelatin" class="b_issuelist__link">Boosting Vaccine Stability with Gelatin</a> </p> </li> <li class="b_issuelist__item "> <span class="b_category__container "> <a href="/discovery-development" class="b_category b_category--color-1 "> Discovery & Development </a> </span> <p class="b_issuelist__headline b_issuelist__headline--h3"> <a href="/discovery-development/lets-make-a-real-difference-in-cancer" class="b_issuelist__link">Let’s Make a Real Difference in Cancer</a> </p> </li> </ul> </div> </div> </div> </div> </div> </div> <footer class="b_footer"> <div class="b_footer__row b_footer__row--menu"> <div class="b_footer__container"> <ul class="b_menu-footer"> <li class="b_menu-footer__item"> <a href="https://texerepublishing.com/our-brands/the-medicine-maker/" target="_blank" rel="noreferrer" class="b_menu-footer__link">About Us</a> </li> <li class="b_menu-footer__item"> <a href="https://texerepublishing.com/careers" target="_blank" rel="noreferrer" class="b_menu-footer__link">Work at Conexiant Europe</a> </li> <li class="b_menu-footer__item"> <a href="https://texerepublishing.com/advertising-services/our-brands/the-medicine-maker" target="_blank" rel="noreferrer" class="b_menu-footer__link">Advertise with us</a> </li> <li class="b_menu-footer__item"> <a href="/cdn-cgi/l/email-protection#066f68606946726e636b63626f656f68636b676d63742865696b" target="_blank" class="b_menu-footer__link">Contact Us</a> </li> <li class="b_menu-footer__item"> <a href="https://texerepublishing.com/our-brands/portfolio" target="_blank" rel="noreferrer" class="b_menu-footer__link">Other Brands</a> </li> </ul> </div> </div> <div class="b_footer__row b_footer__row--social"> <div class="b_footer__container"> <ul class="b_menu-social"> <li class="b_menu-social__item"> <a href="https://www.facebook.com/themedicinemakermag" target="_blank" rel="noreferrer" title="Facebook" class="b_menu-social__link"> </a> </li> <li class="b_menu-social__item"> <a href="https://www.instagram.com/themedicinemaker/" target="_blank" rel="noreferrer" title="Instagram" class="b_menu-social__link"> </a> </li> <li class="b_menu-social__item"> <a href="https://www.youtube.com/channel/UCI2QgHi0YXbeA-aVy-n3SHg" target="_blank" rel="noreferrer" title="YouTube" class="b_menu-social__link"> </a> </li> <li class="b_menu-social__item"> <a href="https://www.linkedin.com/company/themedicinemaker/" target="_blank" rel="noreferrer" title="LinkedIn" class="b_menu-social__link"> </a> </li> <li class="b_menu-social__item"> <a href="https://x.com/medicine_maker" target="_blank" rel="noreferrer" title="X" class="b_menu-social__link"> </a> </li> </ul> </div> </div> <div class="b_footer__row b_footer__row--meta"> <div class="b_footer__container b_footer__container--meta"> <div class="b_footer__metawrap"> <ul class="b_menu-meta"> <li class="b_menu-meta__item"> <a href="/emails/how-can-pharma-recycle-injector-pens" target="_blank" class="b_menu-meta__link">Read the latest Newsletter</a> </li> <li class="b_menu-meta__item"> <a href="/privacy-notice" target="_blank" class="b_menu-meta__link">Privacy Notice</a> </li> <li class="b_menu-meta__item"> <a href="/terms-and-conditions" target="_blank" class="b_menu-meta__link">Terms and Conditions</a> </li> <li class="b_menu-meta__item"> <a href="/tsmm-privacy-notice" target="_blank" class="b_menu-meta__link">TSMM Privacy Notice</a> </li> </ul> <p class="b_footer__copyright">© 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS. </p> </div> <div class="b_footer__logo"> <a href="https://texerepublishing.com/" target="_blank" rel="noreferrer"> <img alt="Texere Publishing Limited (trading as Conexiant)" src="/_assets/b3c028668ed2e6c778f28eb95a188217/Images/conexiant-logo-white.svg" width="300" height="39" loading="lazy" /> </a> </div> </div> </div> </footer> <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script src="/_assets/b3c028668ed2e6c778f28eb95a188217/JavaScript/common-vendor.js?1739366541" type="module"></script> <script src="/_assets/b3c028668ed2e6c778f28eb95a188217/JavaScript/main.js?1739366541" type="module"></script> </body> </html>

CINXE.COM

The science of oligonucleotides is advancing, but advanced manufacturing techniques are needed to optimize their impact